<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">77327</article-id><article-id pub-id-type="doi">10.7554/eLife.77327</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>A phenotype-based forward genetic screen identifies <italic>Dnajb6</italic> as a sick sinus syndrome gene</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-172679"><name><surname>Ding</surname><given-names>Yonghe</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4531-1721</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-268089"><name><surname>Lang</surname><given-names>Di</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund11"/><xref ref-type="other" rid="fund12"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-268090"><name><surname>Yan</surname><given-names>Jianhua</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-268092"><name><surname>Bu</surname><given-names>Haisong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-268091"><name><surname>Li</surname><given-names>Hongsong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-268097"><name><surname>Jiao</surname><given-names>Kunli</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-217478"><name><surname>Yang</surname><given-names>Jingchun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293651"><name><surname>Ni</surname><given-names>Haibo</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293652"><name><surname>Morotti</surname><given-names>Stefano</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-268095"><name><surname>Le</surname><given-names>Tai</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund15"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-154464"><name><surname>Clark</surname><given-names>Karl J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9637-0967</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293653"><name><surname>Port</surname><given-names>Jenna</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-110185"><name><surname>Ekker</surname><given-names>Stephen C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0726-4212</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-268921"><name><surname>Cao</surname><given-names>Hung</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="fund16"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-268093"><name><surname>Zhang</surname><given-names>Yuji</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248871"><name><surname>Wang</surname><given-names>Jun</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="other" rid="fund17"/><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-239956"><name><surname>Grandi</surname><given-names>Eleonora</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund13"/><xref ref-type="other" rid="fund14"/><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293654"><name><surname>Li</surname><given-names>Zhiqiang</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-293655"><name><surname>Shi</surname><given-names>Yongyong</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-268094"><name><surname>Li</surname><given-names>Yigang</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-204974"><name><surname>Glukhov</surname><given-names>Alexey V</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con21"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-55117"><name><surname>Xu</surname><given-names>Xiaolei</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4928-3422</contrib-id><email>xu.xiaolei@mayo.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con22"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03zzw1w08</institution-id><institution>Department of Biochemistry and Molecular Biology, Department of Cardiovascular Medicine, Mayo Clinic</institution></institution-wrap><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/021cj6z65</institution-id><institution>The Affiliated Hospital of Qingdao University &amp; The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao University</institution></institution-wrap><addr-line><named-content content-type="city">Qingdao</named-content></addr-line><country>China</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01y2jtd41</institution-id><institution>Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison</institution></institution-wrap><addr-line><named-content content-type="city">Madison</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Department of Medicine, University of California, San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04dzvks42</institution-id><institution>Division of Cardiology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School Of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f1zfq44</institution-id><institution>Department of Cardiothoracic Surgery, Xiangya Hospital, Central South University</institution></institution-wrap><addr-line><named-content content-type="city">Changsha</named-content></addr-line><country>China</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/004j26v17</institution-id><institution>Department of Cardiovascular Medicine, Jiading District Central Hospital Affiliated Shanghai University of Medicine &amp; Health Science</institution></institution-wrap><addr-line><named-content content-type="city">Shanghai</named-content></addr-line><country>China</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05rrcem69</institution-id><institution>Department of Pharmacology, University of California, Davis</institution></institution-wrap><addr-line><named-content content-type="city">Davis</named-content></addr-line><country>United States</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04gyf1771</institution-id><institution>Department of Biomedical Engineering, University of California, Irvine</institution></institution-wrap><addr-line><named-content content-type="city">Irvine</named-content></addr-line><country>United States</country></aff><aff id="aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04gyf1771</institution-id><institution>Department of Electrical Engineering and Computer Science, University of California, Irvine</institution></institution-wrap><addr-line><named-content content-type="city">Irvine</named-content></addr-line><country>United States</country></aff><aff id="aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04rq5mt64</institution-id><institution>Department of Epidemiology and Public Health, University of Maryland School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Baltimore</named-content></addr-line><country>United States</country></aff><aff id="aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03gds6c39</institution-id><institution>Department of Pediatrics, McGovern Medical School, The University of Texas Health Science Center at Houston</institution></institution-wrap><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Chen</surname><given-names>Wenbiao</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02vm5rt34</institution-id><institution>Vanderbilt University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Stainier</surname><given-names>Didier YR</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0165r2y73</institution-id><institution>Max Planck Institute for Heart and Lung Research</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>18</day><month>10</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e77327</elocation-id><history><date date-type="received" iso-8601-date="2022-02-04"><day>04</day><month>02</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-10-17"><day>17</day><month>10</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-01-26"><day>26</day><month>01</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.01.25.477752"/></event></pub-history><permissions><copyright-statement>© 2022, Ding et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Ding et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-77327-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-77327-figures-v2.pdf"/><related-article related-article-type="article-reference" ext-link-type="doi" xlink:href="10.7554/eLife.54572" id="ra1"/><abstract><p>Previously we showed the generation of a protein trap library made with the gene-break transposon (GBT) in zebrafish (<italic>Danio rerio</italic>) that could be used to facilitate novel functional genome annotation towards understanding molecular underpinnings of human diseases (Ichino et al, 2020). Here, we report a significant application of this library for discovering essential genes for heart rhythm disorders such as sick sinus syndrome (SSS). SSS is a group of heart rhythm disorders caused by malfunction of the sinus node, the heart’s primary pacemaker. Partially owing to its aging-associated phenotypic manifestation and low expressivity, molecular mechanisms of SSS remain difficult to decipher. From 609 GBT lines screened, we generated a collection of 35 zebrafish insertional cardiac (ZIC) mutants in which each mutant traps a gene with cardiac expression. We further employed electrocardiographic measurements to screen these 35 ZIC lines and identified three GBT mutants with SSS-like phenotypes. More detailed functional studies on one of the arrhythmogenic mutants, <italic>GBT411</italic>, in both zebrafish and mouse models unveiled <italic>Dnajb6</italic> as a novel SSS causative gene with a unique expression pattern within the subpopulation of sinus node pacemaker cells that partially overlaps with the expression of hyperpolarization activated cyclic nucleotide gated channel 4 (HCN4), supporting heterogeneity of the cardiac pacemaker cells.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>sick sinus syndrome</kwd><kwd>sinus arrest</kwd><kwd>Dnajb6</kwd><kwd>electrocardiogram</kwd><kwd>genetic diseases</kwd><kwd>zebrafish</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007048</institution-id><institution>Mayo Foundation for Medical Education and Research</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Xu</surname><given-names>Xiaolei</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution>Science and Technology Innovation Action Plan of Shanghai</institution></institution-wrap></funding-source><award-id>201409005600</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Yigang</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institute of Health</institution></institution-wrap></funding-source><award-id>GM063904</award-id><principal-award-recipient><name><surname>Ekker</surname><given-names>Stephen C</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>16SDG29120011</award-id><principal-award-recipient><name><surname>Glukhov</surname><given-names>Alexey V</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institute of Health</institution></institution-wrap></funding-source><award-id>R00HL138160</award-id><principal-award-recipient><name><surname>Morotti</surname><given-names>Stefano</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institute of Health</institution></institution-wrap></funding-source><award-id>R01HL131517</award-id><principal-award-recipient><name><surname>Grandi</surname><given-names>Eleonora</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>15SDG24910015</award-id><principal-award-recipient><name><surname>Grandi</surname><given-names>Eleonora</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>20POST35120462</award-id><principal-award-recipient><name><surname>Ni</surname><given-names>Haibo</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institute of Health</institution></institution-wrap></funding-source><award-id>NIH R01HL141214</award-id><principal-award-recipient><name><surname>Glukhov</surname><given-names>Alexey V</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution>Wisconsin Partnership Program 4140</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Glukhov</surname><given-names>Alexey V</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>17POST33370089</award-id><principal-award-recipient><name><surname>Lang</surname><given-names>Di</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>846898</award-id><principal-award-recipient><name><surname>Lang</surname><given-names>Di</given-names></name></principal-award-recipient></award-group><award-group id="fund13"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institute of Health</institution></institution-wrap></funding-source><award-id>1OT2OD026580-01</award-id><principal-award-recipient><name><surname>Grandi</surname><given-names>Eleonora</given-names></name></principal-award-recipient></award-group><award-group id="fund14"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institute of Health</institution></institution-wrap></funding-source><award-id>P01HL141084</award-id><principal-award-recipient><name><surname>Grandi</surname><given-names>Eleonora</given-names></name></principal-award-recipient></award-group><award-group id="fund15"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R44OD024874</award-id><principal-award-recipient><name><surname>Le</surname><given-names>Tai</given-names></name></principal-award-recipient></award-group><award-group id="fund16"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R44OD024874</award-id><principal-award-recipient><name><surname>Cao</surname><given-names>Hung</given-names></name></principal-award-recipient></award-group><award-group id="fund17"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01HL142704</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Jun</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Dnajb6 is identified as a novel sick sinus syndrome causative gene that exhibits a unique expression pattern within a subpopulation of sinus node pacemaker cells.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Cardiac arrhythmia affects &gt;2% of individuals in community-dwelling adults (<xref ref-type="bibr" rid="bib29">Khurshid et al., 2018</xref>). Sick sinus syndrome (SSS), also known as sinus node dysfunction or sinoatrial node (SAN) disease, is a group of heart rhythm disorders affecting cardiac impulse formation and/or propagation from the SAN, the heart’s primary pacemaker. SSS manifests a spectrum of presentations such as sinus pause or arrest (SA), bradycardia, sinoatrial exit block, or tachy-brady syndrome accompanied by atrial fibrillation (AF) (<xref ref-type="bibr" rid="bib63">Semelka et al., 2013</xref>; <xref ref-type="bibr" rid="bib10">De Ponti et al., 2018</xref>). In addition, 20% to 60% SSS patients show abnormal response to autonomic stresses (<xref ref-type="bibr" rid="bib9">Dakkak and Doukky, 2020</xref>). SSS occurs most commonly in elderly, with an estimated prevalence of 1 case per 600 adults over age 65 (<xref ref-type="bibr" rid="bib15">Dobrzynski et al., 2007</xref>). Symptomatic SSS can lead to inadequate blood supply to the heart and body and contribute significantly to life-threatening problems such as heart failure and cardiac arrest. While SSS is the most common indication for pacemaker implantation worldwide (<xref ref-type="bibr" rid="bib50">Mond and Proclemer, 2011</xref>), the mechanisms of SSS remain poorly understood, making it difficult to stratify SSS risk in vulnerable cohorts of patients and development of effective pharmacologic therapy for pacemaker abnormalities.</p><p>To develop mechanism-based diagnostic and therapeutic strategies for SSS, it is desirable to discover genes that are expressed in the SAN and may contribute to SSS. Unfortunately, very limited number of SSS genes and related animal models are currently available. While mutations in the cardiac sodium channel α-subunit encoding gene (<italic>SCN5A</italic>) (<xref ref-type="bibr" rid="bib55">Nof et al., 2007</xref>; <xref ref-type="bibr" rid="bib68">Tan et al., 2001</xref>) and hyperpolarization-activated cyclic nucleotide-aged channel encoding gene (<italic>HCN4</italic>) <xref ref-type="bibr" rid="bib62">Schulze-Bahr et al., 2003</xref>; <xref ref-type="bibr" rid="bib71">Verkerk and Wilders, 2015</xref> have been found to cause SSS, only a few other genes affecting the structure and/or function of the SAN were identified to increase the risk of developing SSS (<xref ref-type="bibr" rid="bib2">Anderson and Benson, 2010</xref>; <xref ref-type="bibr" rid="bib22">Holm et al., 2011</xref>). Classic human genetic linkage analysis-based approach has played important roles in gene discovery, but it is largely limited by the availability of suitable pedigree, especially in this age-dependent disease (<xref ref-type="bibr" rid="bib75">Zhu et al., 2018</xref>). More recently, the genome-wide association studies (GWASs) have been used to identify novel genetic susceptibility factors associated with SSS (<xref ref-type="bibr" rid="bib22">Holm et al., 2011</xref>; <xref ref-type="bibr" rid="bib51">Monfredi and Boyett, 2015</xref>). However, owing to its statistic and associative nature, it has been difficult to confidently establish genotype-phenotype relationships for the vast amount of variants (<xref ref-type="bibr" rid="bib43">Lin and Musunuru, 2018</xref>; <xref ref-type="bibr" rid="bib67">Tam et al., 2019</xref>). Alternative approaches for effective identification of essential genes for SSS are thus needed.</p><p>Phenotype-based forward genetic screen in model organisms is a powerful strategy for deciphering genetic basis of a biological process. Without any <italic>a prior</italic> assumption, new genes can be identified that shed light on key signaling pathways. However, this approach is difficult to carry out in adult vertebrates, because of significantly increased burden of colony management efforts (<xref ref-type="bibr" rid="bib27">Kamp et al., 2010</xref>; <xref ref-type="bibr" rid="bib64">Shen et al., 2005</xref>). To address this bottleneck, zebrafish, a vertebrate with higher throughput than rodents, has been explored to study cardiac diseases (<xref ref-type="bibr" rid="bib20">Gut et al., 2017</xref>). Despite its small body size, a zebrafish heart has conserved myocardium, endocardium, and epicardium as found in human, and adult zebrafish shows strikingly similar cardiac physiology to humans (<xref ref-type="bibr" rid="bib5">Bakkers, 2011</xref>). Its heart rate is around 100 beats per minute (bpm), which is much comparable to that in human than in rodents. Adult zebrafish models for human cardiac diseases such as cardiomyopathies have been successfully generated (<xref ref-type="bibr" rid="bib13">Ding et al., 2020a</xref>). Besides <italic>N</italic>-ethyl-<italic>N</italic>-nitrosourea (ENU)-based mutagenesis screens that have been conducted to identify embryonic recessive mutants, insertional mutagens such as those based on viruses and/or transposons have been developed to further increase the throughput of the screen, opening doors to screening genes affecting adult phenotypes (<xref ref-type="bibr" rid="bib1">Amsterdam et al., 1999</xref>; <xref ref-type="bibr" rid="bib72">Wang et al., 2007</xref>). Our team recently reported a gene-breaking transposon (GBT)-based gene-trap system in zebrafish which enables to disrupt gene function reversibly at high efficiency (&gt;99% at the RNA level) (<xref ref-type="bibr" rid="bib8">Clark et al., 2011</xref>). Approximately 1,200 GBT lines have been generated, laying a foundation for adult phenotype-based forward genetic screens (<xref ref-type="bibr" rid="bib26">Ichino et al., 2020</xref>).Because the expression pattern of the affected genes in each GBT line is reported by a fluorescence reporter, we enriched GBT lines with cardiac expression and generated a zebrafish insertional cardiac (ZIC) mutant collection (<xref ref-type="bibr" rid="bib11">Ding et al., 2013</xref>). Through stressing the ZIC collection with doxorubicin, an anti-cancer drug, we demonstrated that novel genetic factors of doxorubicin-induced cardiomyopathy (DIC), such as Dnaj (Hsp40) homology, subfamily B, member 6b (<italic>dnajb6b</italic>), sorbin and SH3 domain-containing 2b (<italic>sorbs2b</italic>) and retinoid x receptor alpha a (<italic>rxraa</italic>), could be successfully identified (<xref ref-type="bibr" rid="bib12">Ding et al., 2016</xref>; <xref ref-type="bibr" rid="bib14">Ding et al., 2020b</xref>; <xref ref-type="bibr" rid="bib46">Ma et al., 2020</xref>). Follow up studies on these hits confirmed their identity as important cardiomyopathy genes.</p><p>Encouraged by our success in identifying new genetic factors for DIC, we reasoned that genes for rhythm disorders could be similarly identified by directly screening adult ZIC lines using echocardiographic measurement. We had recently optimized a commercially available ECG system to define SA episodes in an adult zebrafish, and the baseline frequency of aging-associated SSS in wild-type (WT) adult zebrafish (<xref ref-type="bibr" rid="bib74">Yan et al., 2020</xref>). Here, we reported a pilot screen of our ZIC collection using this ECG platform and the resultant discovery of three positive hits, followed by comprehensive expressional and functional analysis of <italic>dnajb6b</italic> gene that is linked to one of the hits. Together, our data prove the feasibility of a phenotype-based screening strategy in adult zebrafish for discovering new rhythm genes.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Identification of 35 zebrafish insertional cardiac (ZIC) mutants</title><p>We recently reported the generation of more than 1200 zebrafish mutant strains using the gene-break transposon (GBT) vector (<xref ref-type="bibr" rid="bib26">Ichino et al., 2020</xref>). The tagged gene in each GBT mutant is typically disrupted with 99% knockdown efficiency and its expression pattern is reported by a monomeric red fluorescent protein (mRFP) reporter <xref ref-type="bibr" rid="bib26">Ichino et al., 2020</xref>. We screened 609 GBT lines based on their mRFP expression and identified 44 mutants with either the embryonic or adult heart expression <xref ref-type="bibr" rid="bib12">Ding et al., 2016</xref>. Then, we outcrossed these 44 lines, aided by Southern blotting to identify offsprings with a lower copy number of insertions, <xref ref-type="bibr" rid="bib11">Ding et al., 2013</xref> and identified 35 mutants with a single copy of the GBT insertion after 2–4 generations of outcross (<xref ref-type="table" rid="table1">Table 1</xref>; <xref ref-type="bibr" rid="bib12">Ding et al., 2016</xref>). Using a combination of inverse PCR and/or 5’- and 3’-RACE PCR cloning approaches, we mapped the genetic loci of GBT inserts in these 35 mutants (<xref ref-type="table" rid="table1">Table 1</xref>; <xref ref-type="bibr" rid="bib11">Ding et al., 2013</xref>). Most of the affected genes have human orthologs with a corresponding Online Mendelian Inheritance in Man (OMIM) number. Because each GBT line contains a single GBT insertion that traps a gene with cardiac expression, these 35 GBT lines were termed as zebrafish insertional cardiac (ZIC) mutants.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Collection of 35 zebrafish insertional cardiac (ZIC) mutants.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">GBT #</th><th align="left" valign="bottom">Gene ID</th><th align="left" valign="bottom">Human ortholog</th><th align="left" valign="bottom">Insertion position</th><th align="left" valign="bottom">OMIM#</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>GBT001</italic></td><td align="left" valign="bottom"><italic>casz1</italic></td><td align="left" valign="bottom"><italic>CASZ1</italic></td><td align="left" valign="bottom">5’ UTR</td><td align="char" char="." valign="bottom">609895</td></tr><tr><td align="left" valign="bottom"><italic>GBT002</italic></td><td align="left" valign="bottom"><italic>sorbs2b</italic></td><td align="left" valign="bottom"><italic>SORBS2</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="char" char="." valign="bottom">616349</td></tr><tr><td align="left" valign="bottom"><italic>GBT103</italic></td><td align="left" valign="bottom"><italic>cyth3a</italic></td><td align="left" valign="bottom"><italic>CYTH3</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="char" char="." valign="bottom">605081</td></tr><tr><td align="left" valign="bottom"><italic>GBT130</italic></td><td align="left" valign="bottom"><italic>lrp1b</italic></td><td align="left" valign="bottom"><italic>LRP1</italic></td><td align="char" char="." valign="bottom">73<sup>rd</sup> intron</td><td align="char" char="." valign="bottom">107770</td></tr><tr><td align="left" valign="bottom"><italic>GBT135</italic></td><td align="left" valign="bottom"><italic>bhlhe41</italic></td><td align="left" valign="bottom"><italic>BHLHE41</italic></td><td align="char" char="." valign="bottom">2<sup>nd</sup> intron</td><td align="char" char="." valign="bottom">606200</td></tr><tr><td align="left" valign="bottom"><italic>GBT136</italic></td><td align="left" valign="bottom"><italic>ano5a</italic></td><td align="left" valign="bottom"><italic>ANO5</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="char" char="." valign="bottom">608662</td></tr><tr><td align="left" valign="bottom"><italic>GBT145</italic></td><td align="left" valign="bottom"><italic>epn2</italic></td><td align="left" valign="bottom"><italic>EPN2</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="char" char="." valign="bottom">607263</td></tr><tr><td align="left" valign="bottom"><italic>GBT166</italic></td><td align="left" valign="bottom"><italic>atp1b2a</italic></td><td align="left" valign="bottom"><italic>ATP1B2A</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="char" char="." valign="bottom">182331</td></tr><tr><td align="left" valign="bottom"><italic>GBT235</italic></td><td align="left" valign="bottom"><italic>Irpprc</italic></td><td align="left" valign="bottom"><italic>LRPPRC</italic></td><td align="char" char="." valign="bottom">22<sup>nd</sup> intron</td><td align="char" char="." valign="bottom">607544</td></tr><tr><td align="left" valign="bottom"><italic>GBT239</italic></td><td align="left" valign="bottom"><italic>map7d1b</italic></td><td align="left" valign="bottom"><italic>MAP7D1</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="left" valign="bottom">NA</td></tr><tr><td align="left" valign="bottom"><italic>GBT249</italic></td><td align="left" valign="bottom"><italic>b2ml</italic></td><td align="left" valign="bottom"><italic>B2M</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="char" char="." valign="bottom">109700</td></tr><tr><td align="left" valign="bottom"><italic>GBT250</italic></td><td align="left" valign="bottom"><italic>ptprm</italic></td><td align="left" valign="bottom"><italic>PTPRM</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="char" char="." valign="bottom">176888</td></tr><tr><td align="left" valign="bottom"><italic>GBT268</italic></td><td align="left" valign="bottom"><italic>idh2</italic></td><td align="left" valign="bottom"><italic>IDH2</italic></td><td align="char" char="." valign="bottom">12<sup>th</sup> intron</td><td align="char" char="." valign="bottom">147650</td></tr><tr><td align="left" valign="bottom"><italic>GBT298</italic></td><td align="left" valign="bottom"><italic>zgc:194659</italic></td><td align="left" valign="bottom"><italic>NA</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="left" valign="bottom">NA</td></tr><tr><td align="left" valign="bottom"><italic>GBT270</italic></td><td align="left" valign="bottom"><italic>zpfm2a</italic></td><td align="left" valign="bottom"><italic>ZFPM2</italic></td><td align="char" char="." valign="bottom">2<sup>nd</sup> intron*</td><td align="char" char="." valign="bottom">603693</td></tr><tr><td align="left" valign="bottom"><italic>GBT299</italic></td><td align="left" valign="bottom"><italic>dph1</italic></td><td align="left" valign="bottom"><italic>DPH1</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="char" char="." valign="bottom">603527</td></tr><tr><td align="left" valign="bottom"><italic>GBT340</italic></td><td align="left" valign="bottom"><italic>nfatc3</italic></td><td align="left" valign="bottom"><italic>NFATC3</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="char" char="." valign="bottom">602698</td></tr><tr><td align="left" valign="bottom"><italic>GBT345</italic></td><td align="left" valign="bottom"><italic>amot</italic></td><td align="left" valign="bottom"><italic>AMOT</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="char" char="." valign="bottom">300410</td></tr><tr><td align="left" valign="bottom"><italic>GBT360</italic></td><td align="left" valign="bottom"><italic>tefm</italic></td><td align="left" valign="bottom"><italic>TEFM</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="left" valign="bottom">NA</td></tr><tr><td align="left" valign="bottom"><italic>GBT361</italic></td><td align="left" valign="bottom"><italic>abr</italic></td><td align="left" valign="bottom"><italic>ABR</italic></td><td align="left" valign="bottom">3’ UTR</td><td align="char" char="." valign="bottom">600365</td></tr><tr><td align="left" valign="bottom"><italic>GBT364</italic></td><td align="left" valign="bottom"><italic>mat2aa</italic></td><td align="left" valign="bottom"><italic>MAT2A</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="char" char="." valign="bottom">601468</td></tr><tr><td align="left" valign="bottom"><italic>GBT386</italic></td><td align="left" valign="bottom"><italic>babam1</italic></td><td align="left" valign="bottom"><italic>BABAM1</italic></td><td align="char" char="." valign="bottom">2<sup>nd</sup> intron</td><td align="char" char="." valign="bottom">612766</td></tr><tr><td align="left" valign="bottom"><italic>GBT402</italic></td><td align="left" valign="bottom"><italic>scaf11</italic></td><td align="left" valign="bottom"><italic>SCAF11</italic></td><td align="char" char="." valign="bottom">2<sup>nd</sup> intron</td><td align="char" char="." valign="bottom">603668</td></tr><tr><td align="left" valign="bottom"><italic>GBT410</italic></td><td align="left" valign="bottom"><italic>vapal</italic></td><td align="left" valign="bottom"><italic>VAPA</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="char" char="." valign="bottom">605703</td></tr><tr><td align="left" valign="bottom"><italic>GBT411</italic></td><td align="left" valign="bottom"><italic>dnajb6</italic></td><td align="left" valign="bottom"><italic>DNAJB6</italic></td><td align="char" char="." valign="bottom">6<sup>th</sup> intron*</td><td align="char" char="." valign="bottom">611332</td></tr><tr><td align="left" valign="bottom"><italic>GBT412</italic></td><td align="left" valign="bottom"><italic>xpo7</italic></td><td align="left" valign="bottom"><italic>XPO7</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="char" char="." valign="bottom">606140</td></tr><tr><td align="left" valign="bottom"><italic>GBT415</italic></td><td align="left" valign="bottom"><italic>arrdc1b</italic></td><td align="left" valign="bottom"><italic>ARRDC1</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="left" valign="bottom">NA</td></tr><tr><td align="left" valign="bottom"><italic>GBT416</italic></td><td align="left" valign="bottom"><italic>csrnp1b</italic></td><td align="left" valign="bottom"><italic>CSRNP1</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron*</td><td align="char" char="." valign="bottom">606458</td></tr><tr><td align="left" valign="bottom"><italic>GBT419</italic></td><td align="left" valign="bottom"><italic>rxraa</italic></td><td align="left" valign="bottom"><italic>RXRA</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron*</td><td align="char" char="." valign="bottom">180245</td></tr><tr><td align="left" valign="bottom"><italic>GBT422</italic></td><td align="left" valign="bottom"><italic>insrb</italic></td><td align="left" valign="bottom"><italic>INSR</italic></td><td align="char" char="." valign="bottom">6<sup>th</sup> intron</td><td align="char" char="." valign="bottom">147670</td></tr><tr><td align="left" valign="bottom"><italic>GBT424</italic></td><td align="left" valign="bottom"><italic>v2rl1</italic></td><td align="left" valign="bottom"><italic>VMN2R1</italic></td><td align="char" char="." valign="bottom">2<sup>nd</sup> intron</td><td align="left" valign="bottom">NA</td></tr><tr><td align="left" valign="bottom"><italic>GBT425</italic></td><td align="left" valign="bottom"><italic>mrps18b</italic></td><td align="left" valign="bottom"><italic>MRPS18B</italic></td><td align="char" char="." valign="bottom">5<sup>th</sup> intron</td><td align="char" char="." valign="bottom">611982</td></tr><tr><td align="left" valign="bottom"><italic>GBT503</italic></td><td align="left" valign="bottom"><italic>stat1a</italic></td><td align="left" valign="bottom"><italic>STAT1</italic></td><td align="char" char="." valign="bottom">6<sup>th</sup> intron*</td><td align="char" char="." valign="bottom">600555</td></tr><tr><td align="left" valign="bottom"><italic>GBT513</italic></td><td align="left" valign="bottom"><italic>map2k6</italic></td><td align="left" valign="bottom"><italic>MAP2K6</italic></td><td align="char" char="." valign="bottom">1<sup>st</sup> intron</td><td align="char" char="." valign="bottom">601254</td></tr><tr><td align="left" valign="bottom"><italic>GBT589</italic></td><td align="left" valign="bottom"><italic>oxsr1b</italic></td><td align="left" valign="bottom"><italic>OXSR1</italic></td><td align="char" char="." valign="bottom">3<sup>rd</sup> intron</td><td align="char" char="." valign="bottom">604046</td></tr></tbody></table><table-wrap-foot><fn><p>OMIM, Online Mendelian Inheritance in Man; NA, not available.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-2"><title>An ECG screen of 35 ZIC lines identified three mutants with increased incidence of SA and/or AV block episodes</title><p>Because each ZIC mutant disrupts a gene with cardiac expression, we enquired whether an ECG screening can be conducted to identify genetic lesions that result in arrhythmia. Since aging is a strong risk factor for heart rhythm disorders, we initially carried our screen in 35 aged ZIC fish lines generated from incrosses to facilitate the manifestation of cardiac rhythm abnormalities (<xref ref-type="table" rid="table1">Table 1</xref>). Because these fish are offsprings of incrosses and have been preselected based on the mRFP tag, their genotypes consist of both heterozygous and homozygous for the affected genes. As reported recently, in WT fish aged around 2 years old, we noted baseline SA episodes in about 1 out of 20 fish (5%) fish <xref ref-type="bibr" rid="bib74">Yan et al., 2020</xref>. By contrast, among the 35 ZIC mutants with mixed heterozygous and homozygous genotypes, we noted an increased incidence of SA in 3 lines, including 3 out of 13 <italic>GBT103</italic> mutant fish at 1.5 years old, 4 out of 10 <italic>GBT410</italic> mutant fish at 2 years old, and 3 out of 8 <italic>GBT411</italic> mutant fish at 2 years old (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). In addition to SA, we also noted incidence of atrioventricular block (AVB) in 4 different <italic>GBT103</italic> mutant animals at 1.5 years of age. Because the increased incidence of SA and/or AVB are hallmarks of SSS, these three lines were thus identified as three candidate SSS-like mutants.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Screening of 35 ZIC lines identified three mutants with increased incidence of SA and/or AVB episodes.</title><p>(<bold>A</bold>) Representative ECG recordings for three heterozygous/homozygous GBT mutants with increased incidence of sinus arrest (SA) and/or atrioventricular block (AVB) episodes compared to WT control. (<bold>B</bold>) RP2 gene-break transposon insertional positions in the three candidate SSS mutants.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77327-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>The <italic>GBT411</italic> mutant displayed aberrant response to autonomic stimuli.</title><p>Shown are changes of HR in <italic>GBT411-/-</italic> homozygous fish at 16 months in response to different autonomic stimuli. N=9–20 animals per group, unpaired student’s <italic>t-</italic>test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77327-fig1-figsupp1-v2.tif"/></fig></fig-group><p>To confirm the linkage between genetic lesions and the SSS-like phenotypes, we focused on homozygous animals for further validation. Because the precise insertional positions for all the 35 ZIC lines have been mapped, all these three homozygous ZIC mutants were easily identified by genotyping PCR <xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig1">Figure 1B</xref>; <xref ref-type="bibr" rid="bib8">Clark et al., 2011</xref>; <xref ref-type="bibr" rid="bib26">Ichino et al., 2020</xref>; <xref ref-type="bibr" rid="bib11">Ding et al., 2013</xref>. In contrast to 5% WT fish whereby SA episodes can be detected, significantly increased SA incidence was noted in all three homozygous mutants at 16 months of age, with an incidence of 57.1% in the <italic>GBT103/cyth3a</italic>, 44.4% in the <italic>GBT410/vapal</italic>, and 40% in the <italic>GBT411/dnajb6b</italic> homozygous mutants, respectively (<xref ref-type="table" rid="table2">Table 2</xref>). There was one animal manifesting AVB in the <italic>GBT103/cyth3a</italic> and <italic>GBT411/dnajb6b</italic> homozygous mutants, respectively. In addition, we also noted a reduced heart rate, another SSS phenotypic trait in the <italic>GBT411/dnajb6b</italic>, but not the other two GBT homozygous mutants (<xref ref-type="table" rid="table2">Table 2</xref>).</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>ECG quantification to validate three GBT lines as SA mutants in homozygous fish.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Genotype</th><th align="left" valign="top">Age</th><th align="left" valign="top">N</th><th align="left" valign="top">SA incidence (%)</th><th align="left" valign="top">AVB incidence (%)</th><th align="left" valign="top">Heart rate (bpm)</th></tr></thead><tbody><tr><td align="left" valign="top">WT</td><td align="char" char="." valign="top">16 m</td><td align="char" char="." valign="top">20</td><td align="char" char="." valign="top">1 (5.0)</td><td align="char" char="." valign="top">0 (0)</td><td align="char" char="plusmn" valign="top">100.1±11.1</td></tr><tr><td align="left" valign="top"><italic>GBT103-/-</italic></td><td align="char" char="." valign="top">16 m</td><td align="char" char="." valign="top">7</td><td align="char" char="." valign="top">4 (57.1)<xref ref-type="table-fn" rid="table2fn2"><sup>*</sup></xref></td><td align="char" char="." valign="top">1 (14.3)</td><td align="char" char="plusmn" valign="top">89.1±9.1.</td></tr><tr><td align="left" valign="top"><italic>GBT410-/-</italic></td><td align="char" char="." valign="top">16 m</td><td align="char" char="." valign="top">9</td><td align="char" char="." valign="top">4 (44.4)<xref ref-type="table-fn" rid="table2fn2"><sup>*</sup></xref></td><td align="char" char="." valign="top">0 (0)</td><td align="char" char="plusmn" valign="top">99.9±17.7</td></tr><tr><td align="left" valign="top"><italic>GBT411-/-</italic></td><td align="char" char="." valign="top">16 m</td><td align="char" char="." valign="top">10</td><td align="char" char="." valign="top">4 (40.0)<xref ref-type="table-fn" rid="table2fn2"><sup>*</sup></xref></td><td align="char" char="." valign="top">1 (10.0)</td><td align="char" char="plusmn" valign="top">90.6±7.5<xref ref-type="table-fn" rid="table2fn2"><sup>*</sup></xref></td></tr></tbody></table><table-wrap-foot><fn><p>N=7-20.</p></fn><fn id="table2fn2"><label>*</label><p>, p&lt;0.05, data are expressed as mean ± SEM. For SA incidence comparison, Chi-square test. For heart rate comparison, unpaired student’s <italic>t-</italic>test.</p></fn><fn><p>SA, sinus arrest. AVB, atrioventricular block. bpm, beats per minute.</p></fn></table-wrap-foot></table-wrap><p>To seek additional evidence supporting our screening strategy, we decided to focus on the <italic>GBT411/dnajb6b</italic> mutant that is also characterized with significantly reduced heart rate phenotype. Detailed analysis of ECG indices showed increased RR interval in the <italic>GBT411/dnajb6b</italic> homozygous mutants (<italic>GBT411<sup>-/-</sup></italic>) (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>), which is consistent with reduced heart rate. No obvious abnormality on other ECG indices was detected. Because arrhythmic mutants often manifest an aberrant response to extrinsic regulation of the heart rate, we examined responses of <italic>GBT411<sup>-/-</sup></italic> to autonomic stimuli by stressing them with three compounds, including isoproterenol, a β-adrenoreceptor agonist for sympathetic nervous system; atropine, an anticholinergic inhibitor; and carbachol, a cholinergic agonist for parasympathetic nervous system. After administrating these drugs to the <italic>GBT411<sup>-/-</sup></italic> fish at 1 year old via intraperitoneal (IP) injection, we noted aberrant heart rate response to both atropine and carbachol, while its response to isoproterenol appeared to be similar to that in WT control animals (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p><p>Next, we stressed the <italic>GBT411<sup>-/-</sup></italic> fish with verapamil, an L-type Ca<sup>2+</sup> channel antagonists, to stress out cardiac pacemaking and unmask SSS phenotype. Indeed, SA incidence was significantly increased in the <italic>GBT411<sup>-/-</sup></italic> fish at 10 months of age (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Similarly, the heart rate was significantly reduced in the <italic>GBT411<sup>-/-</sup></italic> fish compared to WT controls. Together, these data provided additional evidence to support <italic>GBT411/dnajb6b</italic> as an arrhythmia mutant.</p></sec><sec id="s2-3"><title>Dnajb6b and its mouse ortholog exhibit unique expression patterns in the cardiac conduction system</title><p><italic>Dnajb6b</italic> was previously identified as a cardiomyopathy-associated gene, disruption of which led to abnormal cardiac remodeling in zebrafish, <xref ref-type="bibr" rid="bib12">Ding et al., 2016</xref> raising concerns on whether the arrhythmic phenotype in the <italic>GBT411/dnajb6b</italic> mutant is a primary defect in the cardiac conduction system or a consequence of cardiac remodeling in cardiomyocytes. To address this concern, we firstly defined the expression of the Dnajb6b protein in the zebrafish heart. Our previous characterization of the mRFP reporter in the <italic>GBT411/dnajb6b</italic> fish revealed expression of Dnajb6b protein in both the embryonic and the adult hearts <xref ref-type="bibr" rid="bib11">Ding et al., 2013</xref>; <xref ref-type="bibr" rid="bib12">Ding et al., 2016</xref>. To enquire its expression in the cardiac conduction system (CCS), we crossed the <italic>GBT411/dnajb6b</italic> line into the sqET33-mi59B transgenic line in which EGFP labels the zebrafish SAN and atrio-ventricular canal (AVC) cells (<xref ref-type="bibr" rid="bib57">Poon et al., 2016</xref>). Co-localization analysis demonstrated that the mRFP positive, Dnajb6b-expressing cells partially overlap with the EGFP signal labeling both AVC and SAN cells at the base of atrium in the embryonic heart at 3 days post-fertilization (<xref ref-type="fig" rid="fig2">Figure 2A-C</xref>). In the <italic>GBT411/dnajb6b</italic> heterozygous (<italic>GBT411<sup>+/-</sup></italic>) adult hearts crossed with the sqET33-mi59B line, EGFP signal labeling the AVC and SAN cells were consistently detected in all animals (<xref ref-type="fig" rid="fig2">Figure 2D-F</xref>; <xref ref-type="bibr" rid="bib57">Poon et al., 2016</xref>). However, in the <italic>GBT411/dnajb6b</italic> homozygous (<italic>GBT411<sup>-/-</sup></italic>) adult hearts crossed with the sqET33-mi59B line, EGFP signal in the AVC region appeared to be more diffused compared to that in <italic>GBT411<sup>+/-</sup>,</italic> while no EGFP-positive SAN cells was detected in 3 out of 9 fish hearts examined (<xref ref-type="fig" rid="fig2">Figure 2G and H</xref>). Together, these results underscored the expression of Dnajb6b in the CCS, and disruption of <italic>dnajb6b</italic> in the <italic>GBT411<sup>-/-</sup></italic> mutant altered the CCS expression which might contribute to the observed SSS-like phenotypes. It should be noted that the Dnajb6b-mRFP-positive expression patterns overlap with but extend beyond the sqET33-mi59B EGFP-positive expression patterns in both embryonic and adult fish hearts (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Expression and localization of Dnajb6b in zebrafish cardiac conduction system.</title><p>(<bold>A–C</bold>) Co-localization analysis of mRFP in <italic>GBT411/dnajb6b</italic> heterozygous mutant with the reporter line sqET33-mi59B in which EGFP labels cardiac conduction system (CCS) in zebrafish embryos. The mRFP reporter for the <italic>GBT411</italic> tagged Dnajb6b protein partially overlaps with the EGFP reporter in the sqET33-mi59B transgenic line that labels atrio-ventricular canal (AVC) and sinoatrial node (SAN) in embryonic atrium at 3 dpf. Shown in (<bold>B</bold>) and (<bold>C</bold>) are higher magnification images of AVC and SAN in (<bold>A</bold>), respectively. Stars indicate EGFP + cells in the AVC, and arrows indicate EGFP + cells in the SAN. A: atrium. V: ventricle. dpf, days post-fertilization. (<bold>D–H</bold>) Co-localization analysis of EGFP in the <italic>sqET33-mi59B</italic> reporter line after crossed into the <italic>GBT411/dnajb6b</italic> heterozygous mutants (<italic>dnajb6b<sup>GBT411+/-</sup>;sqET33-mi59B</italic>) versus <italic>GBT411/dnajb6b</italic> homozygous mutants (<italic>dnajb6b<sup>GBT411-/-</sup>;sqET33-mi59B</italic>) in adult hearts. In the <italic>dnajb6b<sup>GBT411+/-</sup>;sqET33-mi59B,</italic> EGFP is mostly expressed in the AVC within a group of confined cells, and in SAN forming a ring-like structure, which co-localizes well with mRFP. Shown in (<bold>E</bold>) and (<bold>F</bold>) are higher magnification images of AVC and SAN in (<bold>D</bold>), respectively. In the <italic>dnajb6b<sup>GBT411-/-</sup>;sqET33-mi59B,</italic> EGFP is mostly detected in the AVC with a more diffused pattern. No ring-like structure with EGFP signal was detected in the SAN. Shown in (<bold>H</bold>) are higher magnification images of AVC in (<bold>G</bold>). Scale bars in A, 50 µm; In B, C, 20 µm; In D, G, 500 µm; In E, F, H, 200 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77327-fig2-v2.tif"/></fig><p>To seek additional evidence supporting expression and function of <italic>dnajb6b</italic> in the CCS, we turned to the mouse model. The mouse DNAJB6 protein can be detected in all four cardiac chambers in a sectioned mouse heart tissue (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Interestingly, we found a highly enriched expression of DNAJB6 in the SAN region, as defined by the expression of HCN4 channels which are responsible for the generation of hyperpolarization-activated pacemaker ‘funny’ current in pacemaker cells (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). However, at higher magnification images, only a proportion of DNAJB6-positive cells showed colocalization with the HCN4-positive cells (arrows for colocalized cells vs. stars for non-colocalized cells in <xref ref-type="fig" rid="fig3">Figure 3B</xref>). In addition, co-localization of DNAJB6 with TBX3, a transcription factor that specifies the formation of the SAN cells, was noted (<xref ref-type="fig" rid="fig3">Figure 3C and D</xref>). More interestingly, a negative correlation between DNAJB6 and TBX3 signal intensity was appreciated: cells with strong DNAJB6 expression tend to overlap with cells that show weak TBX3 signal, while cells with weak DNAJB6 expression tend to overlap with the cells with strong TBX3 signal (<xref ref-type="fig" rid="fig3">Figure 3C-E</xref>). Furthermore, the overall TBX3 signal in the SAN tissue of DNAJB6 heterozygous knock out (KO) mouse (see below) was significantly increased compared to that in WT control (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). Together, these results uncovered a unique expression of DNAJB6 in the SAN region which might contribute to SSS development; however, its unique expression patterns also underscored heterogeneity of pacemaker cells within the SAN (<xref ref-type="bibr" rid="bib7">Boyett et al., 2000</xref>; <xref ref-type="bibr" rid="bib42">Liang et al., 2021</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Expression and localization of DNAJB6 in the mouse SAN.</title><p>(<bold>A</bold>) The anti-DNAJB6 antibody immunostaining signal largely overlapped with the HCN4 immunostaining signal in the mouse SAN tissues under low magnification. (<bold>B</bold>) Under higher magnification, expression of DNAJB6 (red) only partially overlapped with HCN4 (green) as revealed by antibody co-immunostaining. Arrows point to cells with overlapping patterns. Stars indicate cells with no-overlapping. (<bold>C</bold>) Shown are fluorescent images after DNAJB6 and TBX3 antibody co-immunostaining indicating expression of DNAJB6 protein in the WT versus <italic>Dnajb6<sup>+/-</sup></italic> +/- mouse SAN. Arrows point to cells with weak DNAJB6 but strong TBX3 immunostaining signal. Stars indicate cells with strong DNAJB6 but low level of TBX3 immunostaining signal. (<bold>D</bold>) Quantification and correlation analysis of DNAJB6 and TBX3 immunostaining signal in WT SAN. (<bold>E</bold>) Quantification analysis of TBX3 signal in the WT versus <italic>Dnajb6</italic>+/- mouse SAN. N=20 cells. Unpaired student’s <italic>t</italic>-test. Scale bars in A, 50 µm; In B, C, D, 20 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77327-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>DNAJB6 is ubiquitously expressed in 4 cardiac chambers in mouse.</title><p>Shown are immunostaining of a whole mice heart section using an anti-DNAJB6 antibody. Scale bar: 50 μm. RA, rigt atrium. RV, right ventricle. LA, left atrium. LV, left ventricle.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77327-fig3-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-4"><title>The <italic>Dnajb6<sup>+/-</sup></italic> mice manifest features of SSS when there is no sign of cardiomyopathy</title><p>To test the conservation of the cardiac arrhythmic functions of <italic>Dnajb6b</italic> suggested from zebrafish, we obtained a global <italic>Dnajb6</italic> KO mouse line. The mutant harbors a deletion of 36,843 bp nucleotides spanning from the first intron to the last intron of <italic>Dnajb6</italic> gene located in the Chromosome 5, which was created by the insertion of the Velocigene ZEN-Ub1 cassette and subsequent LoxP excision using Cre (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Genotyping PCR using a combination of the <italic>Dnajb6</italic> gene-specific and the Zen-Ubi cassette-specific primers was carried out to identify both <italic>Dnajb6</italic> heterozygous (<italic>Dnajb6<sup>+/-</sup></italic>) and homozygous (<italic>Dnajb6<sup>-/-</sup></italic>) KO mice (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). At the protein level, both the DNAJB6 short (S) and long (L) isoforms were reduced by ~50% in <italic>Dnajb6<sup>+/-</sup></italic> mouse embryonic hearts at E12.5 stage (+/-), and near completely depleted in <italic>Dnajb6<sup>-/-</sup></italic> mutant hearts. Consistent with a previous report, <xref ref-type="bibr" rid="bib25">Hunter et al., 1999</xref> <italic>Dnajb6<sup>-/-</sup></italic> KO mice were embryonic lethal, died in the uterus at about E13.5 stage, likely due to the placental defects (data not shown). The <italic>Dnajb6</italic> +/- mice were able to grow to adulthood without visually noticeable phenotypes until at least 1 year of age. Cardiac mechanical function remained normal, as indicated by indistinguishable cardiac echocardiography indices from those of WT siblings at the same age (<xref ref-type="table" rid="table3">Table 3</xref>). No abnormal myocardial structural morphology was detected in the left ventricle (LV) of <italic>Dnajb6</italic><sup>+/-</sup> mice (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). However, increased frequency of SA and AVB episodes, as well as bradycardia phenotype, were noted in <italic>Dnajb6</italic><sup>+/-</sup> mice at 6 months old (<xref ref-type="fig" rid="fig4">Figure 4D and E</xref>, and <xref ref-type="table" rid="table4">Table 4</xref>). Other ECG indices such as PR interval, QRS duration and QT interval remained comparable to WT control (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). Similar to the <italic>GBT411/dnajb6b</italic> mutant in zebrafish, the <italic>Dnajb6</italic><sup>+/-</sup> mice exhibited an impaired response to autonomic stimuli including isoproterenol and carbachol (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Together, these studies suggest that <italic>Dnajb6</italic><sup>+/-</sup> mice manifest SSS phenotype without structural/functional remodeling of the heart.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>Dnajb6<sup>+/-</sup></italic> mice exhibited increased incidence of SA and AVB and impaired response to autonomic stimuli.</title><p>(<bold>A</bold>) Schematics of the <italic>Dnajb6</italic> knockout (KO) mice. The insertion of Velocigene cassette ZEN-Ub1 created a deletion of 36,843 bp nucleotides spanning from the first to the last intron of the <italic>Dnajb6</italic> gene at the Chromosome 5. The neomycin selection cassette was excised after crossed to a Cre expression line. (<bold>B</bold>) Representative DNA gel images of PCR genotyping for identifying WT (300 bp), <italic>Dnajb6<sup>+/-</sup></italic> heterozygous (hets), and <italic>Dnajb6<sup>-/-</sup></italic>homozygous (homo) mutant alleles . (<bold>C</bold>) Western blotting and quantification of DNAJB6 short (S) and long (L) protein expression in WT and <italic>Dnajb6</italic> mutants. N=3 animal per group. (<bold>D</bold>) Shown are representative ECG recordings results showing SA and AVB phenotypes detected in the <italic>Dnajb6<sup>+/-</sup></italic> mice at 6 months. (<bold>E</bold>) The <italic>Dnajb6<sup>+/-</sup></italic> mice manifests impaired response to different autonomic stimuli. N=10–12 mice per group, unpaired student’s <italic>t</italic>-test. SA, sinus arrest. AVB, atrioventricular block.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Uncropped DNA gel image of PCR genotyping for identifying WT and DNAJB6 mutant mouse alleles (in PPT format).</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77327-fig4-data1-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Uncropped Western blot to show expression levels of DNAJB6 short (S) and long (L) proteins in WT and DNAJB6 mutants (in JPG format).</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77327-fig4-data2-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title>Uncropped Western blot to show expression levels of DNAJB6 short (S) and long (L) proteins in WT and DNAJB6 mutants (in PPT format).</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77327-fig4-data3-v2.zip"/></supplementary-material></p><p><supplementary-material id="fig4sdata4"><label>Figure 4—source data 4.</label><caption><title>Uncropped Western blot to show expression levels of DNAJB6 short (S) and long (L) proteins in WT and DNAJB6 mutants (in JPG format).</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77327-fig4-data4-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77327-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>No abnormal myocardium structural remodeling was detected In the <italic>Dnajb6<sup>+/-</sup></italic> mice.</title><p>(<bold>A</bold>) Heart morphology of <italic>Dnajb6<sup>+/-</sup></italic> mice compared to WT control at 1 year of age. (<bold>B</bold>) Quantification analysis of heart weight normalized by body weight (HW/BW) of <italic>Dnajb6<sup>+/-</sup></italic> mice compared to WT control at 1 year of age. N=4, unpaired student <italic>t</italic> test. (<bold>C–E</bold>) Shown are histology images of H&amp;E staining (<bold>C</bold>), Masson’s Trichrome staining (<bold>D</bold>), and transmission electron microscope (<bold>E</bold>) indicating the myocardium structure of <italic>Dnajb6<sup>+/-</sup></italic> mice appeared to be indistinguishable to that in WT control. Scale bars in A, 1 mm; In C, D, 100 µm; In E, 5 um.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77327-fig4-figsupp1-v2.tif"/></fig></fig-group><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>Echocardiography indices in the <italic>Dnajb6<sup>+/-</sup></italic> mice compared to WT controls at 1 year.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top"/><th align="left" valign="top">WT</th><th align="left" valign="top"><italic>Dnajb6+/-</italic></th><th align="left" valign="top">p alue</th></tr></thead><tbody><tr><td align="left" valign="top">Mice number (n)</td><td align="char" char="." valign="top">6</td><td align="char" char="." valign="top">6</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">HR (bpm)</td><td align="char" char="plusmn" valign="top">481±16</td><td align="char" char="plusmn" valign="top">447±11</td><td align="char" char="." valign="top">0.0017</td></tr><tr><td align="left" valign="top">IVSd (mm)</td><td align="char" char="plusmn" valign="top">0.73±0.08</td><td align="char" char="plusmn" valign="top">0.80±0.06</td><td align="char" char="." valign="top">0.0895</td></tr><tr><td align="left" valign="top">LVIDd (mm)</td><td align="char" char="plusmn" valign="top">3.92±0.33</td><td align="char" char="plusmn" valign="top">3.71±0.18</td><td align="char" char="." valign="top">0.2022</td></tr><tr><td align="left" valign="top">LVPWd (mm)</td><td align="char" char="plusmn" valign="top">0.80±0.05</td><td align="char" char="plusmn" valign="top">0.81±0.03</td><td align="char" char="." valign="top">0.5204</td></tr><tr><td align="left" valign="top">IVSs (mm)</td><td align="char" char="plusmn" valign="top">1.10±0.0.07</td><td align="char" char="plusmn" valign="top">1.11±0.08</td><td align="char" char="." valign="top">0.7878</td></tr><tr><td align="left" valign="top">LVIDs (mm)</td><td align="char" char="plusmn" valign="top">2.95±0.26</td><td align="char" char="plusmn" valign="top">2.77±0.15</td><td align="char" char="." valign="top">0.1821</td></tr><tr><td align="left" valign="top">LVPWs (mm)</td><td align="char" char="plusmn" valign="top">1.11±0.06</td><td align="char" char="plusmn" valign="top">1.21±0.12</td><td align="char" char="." valign="top">0.1000</td></tr><tr><td align="left" valign="top">LVEF (%,Cube)</td><td align="char" char="plusmn" valign="top">57.17±5.95</td><td align="char" char="plusmn" valign="top">58.17±3.92</td><td align="char" char="." valign="top">0.7380</td></tr><tr><td align="left" valign="top">LVEF (%, Teich)</td><td align="char" char="plusmn" valign="top">55.50±5.82</td><td align="char" char="plusmn" valign="top">56.67±4.23</td><td align="char" char="." valign="top">0.6996</td></tr><tr><td align="left" valign="top">LVFS (%)</td><td align="char" char="plusmn" valign="top">24.67±3.61</td><td align="char" char="plusmn" valign="top">25.17±2.32</td><td align="char" char="." valign="top">0.7813</td></tr><tr><td align="left" valign="top">LVd Mass (g)</td><td align="char" char="plusmn" valign="top">0.69±0.01</td><td align="char" char="plusmn" valign="top">0.68±0.01</td><td align="char" char="." valign="top">0.7650</td></tr><tr><td align="left" valign="top">LVs Mass (g)</td><td align="char" char="plusmn" valign="top">0.69±0.01</td><td align="char" char="plusmn" valign="top">0.69±0.01</td><td align="char" char="." valign="top">1.0000</td></tr></tbody></table><table-wrap-foot><fn><p>HR, heart rate; bpm, beats per minute; IVSd, Interventricular septum thickness at end–diastole; LVIDd, left ventricular internal dimension at end-diastole; LVPWd, left ventricular internal dimension at end-diastole; IVSs, Interventricular septum thickness at end–systole; LVIDs, Left ventricular internal dimension at end-systole; LVPWs, Left ventricular posterior wall thickness at end–diastole; LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; LVd, left ventricular at end-diastole; LVs, left ventricular at end-systole. Unpaired 2-tailed student’s <italic>t</italic>-test.</p></fn></table-wrap-foot></table-wrap><table-wrap id="table4" position="float"><label>Table 4.</label><caption><title>ECG quantification of <italic>Dnajb6</italic> heterozygous mice at 6 months of age.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Genotype</th><th align="left" valign="top">Age</th><th align="left" valign="top">N</th><th align="left" valign="top">SA incidence (%)</th><th align="left" valign="top">AVB incidence (%)</th><th align="left" valign="top">Heart rate(bpm)</th></tr></thead><tbody><tr><td align="left" valign="top">WT</td><td align="char" char="." valign="top">6 m</td><td align="char" char="." valign="top">20</td><td align="char" char="." valign="top">1 (5.0)</td><td align="char" char="." valign="top">0</td><td align="char" char="plusmn" valign="top">516.3±34.3</td></tr><tr><td align="left" valign="top"><italic>Dnajb6+/-</italic></td><td align="char" char="." valign="top">6 m</td><td align="char" char="." valign="top">44</td><td align="char" char="." valign="top">15 (34.1)<xref ref-type="table-fn" rid="table4fn4"><sup>*</sup></xref></td><td align="char" char="." valign="top">3 (6.8)</td><td align="char" char="plusmn" valign="top">494.8±38.3<xref ref-type="table-fn" rid="table4fn4"><sup>*</sup></xref></td></tr></tbody></table><table-wrap-foot><fn><p>N=20-44.</p></fn><fn id="table4fn4"><label>*</label><p>, p&lt;0.05, data are expressed as mean ± SEM. For SA incidence comparison, Chi-square test. For heart rate comparison, unpaired student’s <italic>t-</italic>test.</p></fn><fn><p>SA, sinus arrest. AVB, atrioventricular block. bpm, beats per minute.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-5"><title>Ex vivo evidences of SAN dysfunction in the <italic>Dnajb6<sup>+/-</sup></italic> mice</title><p>To further prove SAN dysfunction in <italic>Dnajb6<sup>+/-</sup></italic> mice, we performed electrophysiological assessment of SAN pacemaker function by high-resolution fluorescent optical mapping of action potentials from isolated mouse atria at 1 year of age. We firstly analyzed the distribution of the leading pacemaker location site in <italic>Dnajb6<sup>+/-</sup></italic> mice compared to WT control. In WT mice, leading pacemakers were mostly located within the anatomically and functionally defined SAN region <xref ref-type="fig" rid="fig5">Figure 5A and B</xref>; <xref ref-type="bibr" rid="bib20">Gut et al., 2017</xref>; <xref ref-type="bibr" rid="bib17">Glukhov et al., 2010</xref>; <xref ref-type="bibr" rid="bib44">Liu et al., 2007</xref>; <xref ref-type="bibr" rid="bib70">Verheijck et al., 2001</xref>. In contrast, significant increase in the number of leading pacemakers located outside of the SAN, including the subsidiary atrial pacemakers and inter-atrial septum pacemakers, was observed in <italic>Dnajb6<sup>+/-</sup></italic> mice (p=0.039 vs. WT mice). In addition, in <italic>Dnajb6<sup>+/-</sup></italic> mice, we also found a highly irregular heart rate, accompanied by the presence of multiple competing pacemakers and a beat-to-beat migration of the leading pacemaker between various sites which included SAN, right atrial ectopic (subsidiary) pacemakers, and inter-atrial septum (<xref ref-type="fig" rid="fig5">Figure 5C and D</xref>). Similar to the results from the in vivo studies, bradycardia phenotype was consistently detected in the isolated atrial preparations as well (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). Optical mapping on isolated atrial preparations further revealed different responses of heart rate during isoproterenol, atropine, and carbachol stimulations in <italic>Dnajb6<sup>+/-</sup></italic> mice. Significantly increased cycle length (CL) variations were also observed at baseline and upon carbachol stimulation (<xref ref-type="fig" rid="fig5">Figure 5F</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>SAN dysfunction in the <italic>Dnajb6<sup>+/-</sup></italic> mice.</title><p>(<bold>A</bold>) Leading pacemakers were located and plotted from both WT (blue dots) and <italic>Dnajb6<sup>+/-</sup></italic> (red dots) mice. One mouse could have multiple leading pacemaker locations due to the competing pacemakers and ectopic activities. SVC and IVC, superior and inferior vena cava; RAA, right atrial appendage; CT, crista terminalis; IAS, inter-atrial septum; AVN, atrioventricular node. Distribution of the leading pacemakers is summarized in panel. (<bold>B</bold>) Majority of leading pacemakers located within the SAN area in WT, whereas, in <italic>Dnajb6<sup>+/-</sup></italic> mice, significant increase of leading pacemakers locating in subsidiary pacemaker area and IAS was observed. p-value by Fisher exact test. (<bold>C–D</bold>) Activation map based on the optical mapping of action potentials showed representative leading pacemaker locations in WT (SAN) and <italic>Dnajb6<sup>+/-</sup></italic> mice (SAN and IAS areas). (<bold>E</bold>) Optical mapping on isolated atrial preparation showed bradycardia (baseline) and different responses of heart rate during isoproterenol, atropine, and carbachol stimulations between WT and <italic>Dnajb6<sup>+/-</sup></italic> mice. N=7–9 mice per group. Unpaired student’s <italic>t</italic>-test. (<bold>F</bold>) Increased cycle length (CL) variation was observed in <italic>Dnajb6<sup>+/-</sup></italic> isolated atrial preparations during different autonomic stimulations. N = 7–9 mice per group, unpaired student’s <italic>t</italic>-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77327-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Sinus node recovery time was prolonged in the <italic>Dnajb6<sup>+/-</sup></italic> mice.</title><p>(<bold>A–B</bold>) Representative activation maps reconstructed for the last pacing stimulus (<bold>S1</bold>) and the first spontaneous post-pacing atrial beat (<bold>A1</bold>) during SAN recovery time (SANRT) measurements are shown. A site of the earliest atrial activation is labeled by a white asterisk. In <italic>Dnajb6<sup>+/-</sup></italic> group, unlike WT, the first spontaneous post-pacing atrial beat (<bold>A1</bold>) originated from an ectopic location outside of the anatomically and functionally defined SAN area. (<bold>C</bold>) Summarized data for corrected SANRT (+/-) measured during different autonomic stimulations is shown. N=7–9 mice per group, unpaired student’s <italic>t</italic>-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77327-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Fibrotic tissue content in atrial and SAN myocardium of <italic>Dnajb6<sup>+/-</sup></italic>vs.WT mice.</title><p>(<bold>A–B</bold>) Masson’s Trichrome (<bold>A</bold>) and Picrosirius Red (<bold>B</bold>) staining of WT and <italic>Dnajb6<sup>+/-</sup></italic> mice are shown for left (LAA) and right (RAA) atrial appendages as well as SAN regions. Below the representative images, summarized data for fibrotic to myocardial tissue ratio are shown for each staining. N=4 mice per group. Scale bars, 100 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77327-fig5-figsupp2-v2.tif"/></fig></fig-group><p>Furthermore, in <italic>Dnajb6<sup>+/-</sup></italic> mice, we found significant prolongation of the SAN recovery time corrected to beating rate (cSANRT) measured both at baseline and under autonomic stresses, including stimulation by isoproterenol, carbachol, and atropine (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>), confirming the presence of SAN dysfunction in <italic>Dnajb6<sup>+/-</sup></italic> mice. Optical mapping also showed that, unlike WT, the first spontaneous post-pacing atrial beats during SANRT measurements in <italic>Dnajb6<sup>+/-</sup></italic> mice were originated from ectopic locations outside of the SAN (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A, B</xref>), further supporting a suppressed SAN function. Histological evaluation of fibrosis tissue content in <italic>Dnajb6<sup>+/-</sup></italic> mouse atria, however, did not reveal any significant difference compared to WT mice, for both atria and SAN.</p></sec><sec id="s2-6"><title>Computational analysis of the cellular mechanisms underlying the SSS phenotype</title><p>To determine the potential cellular/ionic mechanisms underlying the observed SSS phenotype in the <italic>Dnajb6<sup>+/-</sup></italic> mice , we utilized a population-based computational modeling approach. We used our previously published model of the mouse SAN myocyte to generate a population of 10,000 model variants by randomly varying selected model parameters (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>; <xref ref-type="bibr" rid="bib53">Morotti et al., 2021</xref>). In each variant, we simulated both sympathetic and parasympathetic stimulations and recorded baseline heart rate and heart rate responses to autonomic stimuli. Simulations of both our original model and population predicted an increase in heart rate with isoproterenol and heart rate slowing with carbachol. Nevertheless, the cell-cell variability in heart rate response allowed identifying two subpopulations of model variants, whereby several models (n=438) displayed a slower firing rate at baseline, an increased response to isoproterenol, and a decreased response to carbachol administration (<xref ref-type="fig" rid="fig6">Figure 6C and D</xref>), thus recapitulating the <italic>Dnajb6<sup>+/-</sup></italic> mice as measured in our ex vivo functional experiments (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). The WT subpopulation comprised of the remaining n=6995 models. To reveal the ionic processes that are associated with the observed electrophysiological differences in <italic>Dnajb6<sup>+/-</sup></italic> vs. WT, we then compared the parameter values ( the randomly applied scaling factors) in the two model subpopulations and found significant differences in several model parameters (<xref ref-type="fig" rid="fig6">Figure 6D–F</xref>). The analysis revealed a significant decrease in the maximal conductance of the fast (Na<sub>v</sub>1.5) Na<sup>+</sup> current, the L-type Ca<sup>2+</sup> current (<italic>I</italic><sub>Ca,L</sub>), the transient outward, sustained, and acetylcholine-activated K<sup>+</sup> currents, the background Na<sup>+</sup> and Ca<sup>2+</sup> currents, as well as the ryanodine receptor maximal release flux of the <italic>Dnajb6<sup>+/-</sup></italic> vs. WT model variants. We also found a significant increase in the Na<sup>+</sup>/Ca<sup>2+</sup>-exchanger maximal transport rate, and conductance of the T-type Ca<sup>2+</sup> current and the slowly-activating delayed rectifier K<sup>+</sup> current.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Computational analysis of the cellular mechanisms underlying the SSS phenotype observed in ex vivo mouse experiments.</title><p>(<bold>A</bold>) Time course of membrane potential (E<sub>m</sub>) predicted simulating our computational model of mouse SAN myocyte before (baseline) and after administration of isoproterenol (ISO) or carbachol (CCh). (<bold>B</bold>) Histogram illustrating the effects of ISO and CCh administration on firing rate (HR) distribution in our population of models. (<bold>C</bold>) Scatter plot quantifying HR variation in each model in the population. Red dots correspond to model variants resembling properties observed in ex vivo <italic>Dnajb6</italic><sup><italic>+/</italic>-</sup> mouse experiments ( +/- slower baseline HR, enhanced response to ISO, and reduced response to CCh), while the remaining model variants in grey mimic WT mouse functional measurements. (<bold>D</bold>) Histograms comparing the distribution of baseline HR in the two subgroups, and bar graphs reporting average ( ± SD) baseline HR, and relative HR variation after ISO and CCh administration in the two subgroups. (<bold>E</bold>) Bar graph reporting the differences between average model parameters’ scaling factors in the two subgroups. Note that a positive (negative) bar corresponds to increased (decreased) average parameter value in <italic>Dnajb6<sup>+/-</sup></italic> vs. WT groups. Asterisks in panels D and E indicate significant difference according to the 2-sided Wilcoxon rank sum test (performed with the MATALB function <italic>ranksum</italic>). (<bold>F</bold>) Statistical analysis on the values of scaling factors of selected model parameters (G<sub>CaL</sub>, v<sub>NCX</sub>, v<sub>RyR</sub>, and G<sub>K,ACh</sub>) performed with the MATLAB command <italic>boxplot</italic>. The central line indicates the median of each group (<bold>q<sub>50</sub></bold>). The central box represents the central +/- % of the data, with lower and upper boundaries corresponding, respectively, to the 25<sup>th</sup> and 75<sup>th</sup> percentiles (<bold>q<sub>25</sub> and q<sub>75</sub></bold>). The dotted vertical lines extend to 1.5 times the height of box, and individual values falling outside this range (shown here with grey circles) are considered outliers. The extremes of the lateral notches of the central box (determined as q<sub>50</sub> ± 1.57(q<sub>75</sub>–q<sub>25</sub>)/sqrt(<italic>n</italic>), where <italic>n</italic> is the number of observations in each group) mark the 95% confidence interval for the medians. When the notches from two boxplots do not overlap, as in the four cases shown here, one can assume that the medians are different with a significance level of 0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77327-fig6-v2.tif"/></fig></sec><sec id="s2-7"><title>Transcriptome analysis of the <italic>Dnajb6<sup>+/-</sup></italic> mutant hearts identifies altered genes encoding ion channels and proteins in the Wnt/beta-catenin pathway</title><p>To further seek molecular mechanisms underlying the SSS phenotypes observed in <italic>Dnajb6<sup>+/-</sup></italic> mice, we performed whole transcriptome RNA-sequencing experiments using right atrial tissues isolated from <italic>Dnajb6<sup>+/-</sup></italic> mice WT mice at 1 year of age. Transcriptomes of biological replicates for <italic>Dnajb6<sup>+/-</sup></italic> mice did form a cluster that differs from the cluster for WT control samples, as indicated by principal component analysis (PCA) (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>). Based on a cut-off of adjusted p-value &lt;0.05 and≥2 folds change, 107 differentially expressed (DE) genes were identified, among which 37 genes were upregulated and 70 genes were downregulated in the <italic>Dnajb6<sup>+/-</sup></italic> mice compared with WT controls (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B, C</xref>). Through Ingenuity pathway analysis (IPA), several diverse signaling pathways were identified to be altered in the <italic>Dnajb6<sup>+/-</sup></italic> mice (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1D</xref>). Among these 107 differentially expressed genes, we noted calcium handling related protein-encoding genes like <italic>Slc24a2 and Cdh20</italic>, ion channel-encoding genes including <italic>Slc9a3r1, Kcnh7, Fxyd5, and Gjb5</italic> (<xref ref-type="fig" rid="fig7">Figure 7A</xref>), as well as 4 Wnt pathway related genes (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). We then performed quantitative RT-PCR analysis and experimentally confirmed dysregulation of these genes in the <italic>Dnajb6<sup>+/-</sup></italic> mice (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). The data on calcium handling and ion channel-encoding genes are in line with the SAN dysfunction phenotype observed in the <italic>Dnajb6<sup>+/-</sup></italic> mice. Because Wnt signaling has been shown to direct pacemaker cell specification during SAN morphogenesis, <xref ref-type="bibr" rid="bib41">Liang et al., 2020</xref>; <xref ref-type="bibr" rid="bib59">Ren et al., 2019</xref> the identification of 4 Wnt pathway related genes suggested that this SAN developmental pathway might play an important role in the observed SAN dysfunction phenotype in the adult <italic>Dnajb6<sup>+/-</sup></italic> mice. Future studies are warranted to test this possibility.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Transcriptomes are altered in the atrium of <italic>Dnajb6<sup>+/-</sup></italic> mice.</title><p>(<bold>A</bold>) Expression of six calcium homeostasis and ion channel related genes were altered in the <italic>Dnajb6<sup>+/-</sup></italic> mice right atrium. (<bold>B</bold>) Expression of four Wnt pathway related genes were altered in the <italic>Dnajb6<sup>+/-</sup></italic> mice right atrium. (<bold>C</bold>) Quantitative polymerase chain reaction (qPCR) validation of DE genes listed in A and B, normalized to Gapdh; RNA was extracted from an individual moue right atrium, which was considered a single biological replicate. Samples were collected in triplicate. N=3 mice per group, unpaired student’s <italic>t</italic>-test.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>A list of 107 differentially expressed genes identified between DNAJB6+/- knockout and WT mouse.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-77327-fig7-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77327-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>RNA sequencing identifies transcriptome changes in the <italic>Dnajb6<sup>+/-</sup></italic> mice atrium.</title><p>(<bold>A</bold>) Principal component analysis (PCA) reveals the variance in transcriptome distribution in the <italic>Dnajb6<sup>+/-</sup></italic> mice and WT controls at 6 months. Each point represents the projections of individual hearts onto principal component (PC). (<bold>B</bold>) Heatmap of genes differentially expressed in the <italic>Dnajb6<sup>+/-</sup></italic> mice and WT controls. Each column represents an individual replicate and there are 3 replicates per group. Each row represents an individual gene. The color bar represents relative expression of log-transformed, normalized counts with upregulated genes shown in red and downregulated genes in blue. (<bold>C</bold>) Volcano plot shows magnitude and significance of genes that altered in distribution in the <italic>Dnajb6<sup>+/-</sup></italic> mice and WT controls. Genes that significantly downregulated in the <italic>Dnajb6<sup>+/-</sup></italic> mice are plotted in blue (left) and upregulated are plotted in red (right). (<bold>D</bold>) Ingenuity Pathway Analysis (IPA) of differentially expressed genes in the <italic>Dnajb6<sup>+/-</sup></italic> mice and WT controls. Signaling pathways are organized in the order of significance as –log10 of P value.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77327-fig7-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-8"><title>Identification of <italic>DNAJB6</italic> sequence variants associated with human SSS patients</title><p>To investigate the potential role of <italic>DNAJB6</italic> in human SSS, we queried a sequence variant dataset derived from a genome-wide association study (GWAS) of 6,469 SSS cases and 1,000,187 controls <xref ref-type="bibr" rid="bib69">Thorolfsdottir et al., 2021</xref>. Out of 313 variants with minor allele frequency ≥1% in <italic>DNAJB6</italic>, four variants showed nominal association (p&lt;0.05, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Although none of the four variants survived Bonferroni correction, it’s interesting that two were located in untranslated regions. The most significant variant was observed for <italic>rs754941044</italic> (p=0.0193), which was predicted as a splice acceptor variant by the Ensembl variant effect predictor <xref ref-type="bibr" rid="bib48">McLaren et al., 2016</xref>. Thus, it is likely this variant has a significant impact on <italic>DNAJB6</italic> gene function.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><sec id="s3-1"><title>GBT lines enable a phenotype-based screening approach for discovering new SSS genes</title><p>This work is based on recent establishment of a GBT protein trap-based insertional mutagenesis screening strategy and the generation of a collection of 1,200 zebrafish mutant strains <xref ref-type="bibr" rid="bib26">Ichino et al., 2020</xref>. Here, we demonstrated the feasibility of screening these GBT lines for discovering new genetic factors for SSS, an aging-associated human disease. To overcome the challenge of colony management efforts that is associated with an adult screen, we leveraged the following unique advantages of the GBT vectors and zebrafish models. First, the knockdown efficiency for the tagged gene in each GBT homozygous mutant is consistently high, which is typically &gt;99%, which ensued the success of an adult screen. Second, because of a fluorescence tag, heterozygous GBT fish can be easily identified under a fluorescent microscope without the need of genotyping. As a consequence, a cardiac expression-based enrichment strategy can be used to identify ZIC lines. Instead of screening 609 GBT lines, only 35 ZIC lines need to be screened, which significantly reduced the workload. We acknowledge that some genes with extremely weak cardiac expression might be missed; however, this is not a concern during the early phase of a genome-wide screen. Third, it is economically feasible to house hundreds of mutant fish lines with different genetic lesions to 1–3 years old. Finally, we optimized an ECG technology, defined the baseline SSS in WT fish, and implemented heat-stress to zebrafish at old ages, which shall increase the SSS phenotypic expressivity.</p><p>While the forward genetic screening approach has been successfully utilized to pinpoint genetic basis of cardiogenesis in embryonic fish and doxorubicin-induced cardiomyopathy (DIC) in adult zebrafish, <xref ref-type="bibr" rid="bib1">Amsterdam et al., 1999</xref>; <xref ref-type="bibr" rid="bib12">Ding et al., 2016</xref> this study extended this powerful genetic approach to adult zebrafish for discovering genetic factors associated with rhythm disorders. Given very little knowledge of molecular underpinnings of SSS, the development of this novel approach is significant. Human genetics approach has been difficult, partially owing to the aging associated nature - SSS-like phenotypes at its early stage are often missed, because SA episodes cannot be detected if the ECG measurement only covers a short time window. It takes years in patients to develop from asymptotic to onset of SSS symptoms. Moreover, human genetic studies of SSS are typically confounded by complicated environmental factors, which are minimalized in our zebrafish forward genetic approach - each ZIC mutant is maintained in a well-controlled living environment, and the only difference among different ZIC lines is a single genetic deficiency.</p></sec><sec id="s3-2"><title><italic>DNAJB6</italic> is a new SSS gene with a unique expression in SAN</title><p>The human <italic>DNAJB6</italic> gene encodes a molecular chaperone protein of the heat shock protein 40 (Hsp40) family. DNAJB6 has been previously linked to neurodegenerative diseases via its function in protein folding and the clearance of polyglutamine stretches (polyQ), <xref ref-type="bibr" rid="bib16">Gillis et al., 2013</xref>; <xref ref-type="bibr" rid="bib21">Hageman et al., 2010</xref> and to muscular dystrophy via its protein-protein interaction with Bag3 in the sarcomere <xref ref-type="bibr" rid="bib61">Sarparanta et al., 2012</xref>. Our previous forward genetic screen in adult zebrafish identified <italic>GBT411/dnajb6b</italic> as a deleterious modifier for DIC <xref ref-type="bibr" rid="bib12">Ding et al., 2016</xref>. Here, we provided several lines of evidence in both fish and mouse models, suggesting new functions of <italic>Dnajb6</italic> as a genetic factor for arrhythmia/SSS. First, <italic>GBT411/dnajb6b</italic> is one of three ZIC lines with SSS-like phenotypes that were identified from a screen of 607 GBT lines that is independent of the previous DIC screen. Second, in zebrafish, the increased incidence of SA episodes and reduced heart rate, two main features of SSS, were detected in as early as 10-month-old <italic>GBT411/dnajb6b</italic> homozygous fish. Similarly, bradycardia and SA episodes were noted in <italic>Dnajb6<sup>+/-</sup></italic> KO mice at 6 months old, when the structural remodeling in both left ventricular and atrial myocardium have not occurred yet, and echocardiography indices remained indistinguishable from their age-matched siblings. Depletion of <italic>Dnajb6</italic> in mice manifests severer phenotypes than in zebrafish, probably because mouse has only one <italic>DNAJB6</italic> homologue, while zebrafish has two <italic>DNAJB6</italic> homologues, <italic>dnajb6b</italic> and <italic>dnajb6a</italic>. Third, consistent with loss-of-function studies, DNAJB6 expression was detected in the SAN of both zebrafish and mice. Importantly, DNAJB6 is highly enriched in the SAN region of the mouse comparing to the surrounding atrial tissue. Fourth, transcriptome analysis of <italic>Dnajb6<sup>+/-</sup></italic> mice uncovered altered expression of genes involved in calcium handing, ion channels, and Wnt signaling pathway, which have been linked to the formation/function of the SAN during development. Thus, our data from mice strongly suggested that the observed SSS is not a consequence of <italic>Dnajb6</italic> cardiomyopathy, Instead, the irregular heartbeat is most likely a direct consequence of Dnajb6 depletion in pacemaker cells, subsequently contributing to the pathogenesis of cardiomyopathy that occurs later. To ultimately confirm this hypothesis and to discern functions of Dnajb6 in SAN pacemakers from working cardiomyocytes, a tissue-specific KO line for <italic>Dnajb6</italic> needs to be generated and studied. Prompted by our preliminary success in identifying potentially significant sequence variances for <italic>DNAJB6</italic> from human SSS patients, future human genetic studies are warranted to search more sequence variants and to confirm their pathogenicity, which are required to firmly establish <italic>DNAJB6</italic> as a new <italic>SSS</italic> causative gene in human.</p><p>Detailed examination of DNAJB6 expression in the SAN uncovered unique expression patterns. While the expression of DNAJB6 is detected in the SAN (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), we found a partial co-expression with one of the main pacemaker protein HCN4: DNAJB6-positive cells overlap only with a portion of the HCN4-positive cells (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). The unique expression pattern of DNAJB6 is also underscored by a negative correlation between the expression level of DNAJB6 and TBX3 (<xref ref-type="fig" rid="fig3">Figure 3C and D</xref>), as TBX3 is one of the main transcriptional regulators to define pacemaker cell specificity <xref ref-type="bibr" rid="bib24">Hoogaars et al., 2007</xref>; <xref ref-type="bibr" rid="bib49">Mohan et al., 2020</xref> While these results may sound surprising, studies on isolated SAN cells reported dramatic variability in the density of HCN4-formed ‘funny’ current <italic>I</italic><sub>f</sub> <xref ref-type="bibr" rid="bib23">Honjo et al., 1996</xref>; <xref ref-type="bibr" rid="bib47">Mangoni and Nargeot, 2001</xref>; <xref ref-type="bibr" rid="bib52">Monfredi et al., 2018</xref>; <xref ref-type="bibr" rid="bib73">Wilders et al., 1996</xref>. In spontaneously beating cardiomyocytes isolated from the rabbit SAN, Monfredi et al. showed that <italic>I</italic><sub>f</sub> density can range from 0 to ~50 pA/pF and some the spontaneously beating SAN cells may have little to zero <italic>I</italic><sub>f</sub> <xref ref-type="bibr" rid="bib52">Monfredi et al., 2018</xref>. The authors further observed SAN cells with lower <italic>I</italic><sub>f</sub> current densities, demonstrating a significantly greater sensitivity to inhibition of Ca<sup>2+</sup> clock component of the SAN pacemaking machinery by cyclopiazonic acid, a moderate disruptor of Ca<sup>2+</sup> cycling, in terms of beating rate slowing. The authors also noted that a relatively large cell population (21 of 90 cells) stopped beating when the sarcoplasmic reticulum pumping rate decreased in the presence of cyclopiazonic acid, despite a relatively high <italic>I</italic><sub>f</sub> density. Together with other studies, <xref ref-type="bibr" rid="bib7">Boyett et al., 2000</xref>; <xref ref-type="bibr" rid="bib30">Kim et al., 2018</xref> these results may indicate a significant functional heterogeneity of pacemaker cells within the SAN in terms of their spontaneous beating rate, ion channel and calcium handling protein expression repertoire, and molecular mechanisms of their pacemaker activities. The latter was recently linked to the balance between the voltage and calcium components of the coupled-clock pacemaker system describing mechanisms of SAN automaticity <xref ref-type="bibr" rid="bib33">Lakatta et al., 2010</xref>. As summarized in details in our recent review, <xref ref-type="bibr" rid="bib36">Lang and Glukhov, 2021</xref> it was suggested that pacemaker cells, which primary rely on the Ca<sup>2+</sup> clock, are more sensitive to the autonomic modulation through cAMP-mediated regulation of phosphorylation of Ca<sup>2+</sup> handling proteins <xref ref-type="bibr" rid="bib30">Kim et al., 2018</xref>. This is in line with our findings indicating that DNAJB6 is mainly expressed in SAN cells with low HCN4 density (<xref ref-type="fig" rid="fig3">Figure 3B</xref>) and that <italic>Dnajb6</italic> knock-out activates the expression of transcription factor TBX3 and affects calcium homeostasis genes (<xref ref-type="fig" rid="fig7">Figure 7</xref>) and leads to abnormal autonomic regulation of the SAN (<xref ref-type="fig" rid="fig4">Figure 4E</xref> and <xref ref-type="fig" rid="fig5">Figure 5</xref>).</p></sec><sec id="s3-3"><title>Potential mechanisms underlying the role of <italic>Dnajb6</italic> in SSS</title><p>Besides uncovering a crucial role of DNAJB6 in SAN automaticity and autonomic regulation and specification of SAN pacemaking, our studies raised several hypotheses on the underlying cellular and molecular mechanisms. Our model-based analysis provided pilot screening of potential cellular/ionic targets that could contribute to the observed SSS phenotype in <italic>DNAJB6<sup>+/-</sup></italic> mice. Direct testing of these mechanisms would require a substantial amount of single SAN cell patch clamp and confocal microscopy experiments that can be further pursued in a follow-up study. Importantly, these new in silico experiments add another conceptual level to a phenotype-based high-throughput screening approach introduced in the current study to identify genetic factors associated with SAN dysfunction.</p><p>In addition to SSS phenotype, we observed enhanced ectopic activity in the <italic>Dnajb6<sup>+/-</sup></italic> mice that was associated with subsidiary atrial pacemakers (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>). Based on the diffused AV canal signal and SAN signal loss in the <italic>GBT411/dnajb6b</italic> homozygous mutant fish hearts (<xref ref-type="fig" rid="fig2">Figure 2D</xref>), as well as a negatively correlated expression of DNAJB6 with TBX3 in the mouse SAN tissues (<xref ref-type="fig" rid="fig3">Figure 3C and D</xref>), we speculate that DNAJB6 might act as a suppressor of TBX3 transcription factor to define SAN cell specification. This potential mechanism is also supported by the observation in mice that loss-of-function of <italic>Dnaj6b</italic> results in conduction system defects and ectopic pacemaker activity. Since TBX3 suppresses chamber myocardial differentiation, <xref ref-type="bibr" rid="bib4">Bakker et al., 2008</xref> upregulation of TBX3 may thus contribute to enhanced atrial ectopic activity observed in <italic>Dnajb6<sup>+/-</sup></italic>mic. Furthermore, TBX3 has been recently identified as component of the Wnt/β-catenin-dependent transcriptional complex, <xref ref-type="bibr" rid="bib76">Zimmerli et al., 2020</xref> which is significantly affected in <italic>Dnajb6<sup>+/-</sup></italic> mice (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). This further indicates a possible role of TBX3 in both SAN and atrial remodeling.</p><p>In the human hearts, all the observed ectopic pacemakers were located within the region of extensive distributed system of atrial pacemakers (i.e. atrial pacemaker complex), which includes but extends well beyond an anatomically defined SAN <xref ref-type="bibr" rid="bib6">Boineau et al., 1988</xref>. Under physiological conditions, spontaneous activity of subsidiary pacemakers is overdrive suppressed by the SAN. However, when SAN function is diminished (i.e. during SSS), subsidiary pacemakers can produce escape beats leading to pacemaker irregularities and significant heart rate lability. Though the subsidiary pacemakers can provide a relatively regular rhythm, they are characterized by a slower resting heart, slower exertional heart rates, a prolonged post-pacing recovery time (a parameter similar to SAN recovery time but for non-SAN pacemakers), and an increased beat-to-beat heart rate variability <xref ref-type="bibr" rid="bib54">Morris et al., 2013</xref>. Furthermore, the electrical activity of this subsidiary pacemakers is more akin to that of the SAN than to the surrounding atrial muscle; the subsidiary pacemaker action potential exhibits prominent diastolic depolarization and a significantly lower maximum diastolic potential, take-off potential, overshoot, rate of rise, and amplitude than typical atrial muscle <xref ref-type="bibr" rid="bib60">Rozanski et al., 1984</xref>. Finally, while being bradycardic in general, subsidiary atrial pacemakers can contribute to the development of atrial tachycardia <xref ref-type="bibr" rid="bib31">Kistler et al., 2006</xref>. Therefore, we hypothesize that TBX3 overexpression observed in <italic>Dnajb6<sup>+/-</sup></italic> mice, could further facilitate pacemaker activity in cells within the extended atrial pacemaker complex and, maybe, promote atrial arrhythmogenesis in the setting of profound structural remodeling.</p></sec><sec id="s3-4"><title>A phenotype-based screening approach would facilitate the elucidation of molecular basis of SSS</title><p>Besides <italic>dnajb6b</italic>, our pilot forward genetic screen also suggested two additional candidate SSS genes like <italic>cyth3a</italic> and <italic>vapal</italic>, pending more experimental evidence to confirm their function. This forward genetic screening approach is scalable to the genome, which would generate a comprehensive list of candidate genes for SSS. Because there are at least three major cell types in the SAN region, including pacemaker cells in SAN that generate rhythm, paranodal areas and transition cells in the atrium that transmit the signal from pacemaker cells to govern coordinated contraction of the heart from atrium and then to the ventricle, <xref ref-type="bibr" rid="bib39">Li et al., 2017</xref>; <xref ref-type="bibr" rid="bib40">Li et al., 2020</xref> newly identified SSS genes could be categorized into different groups based on their expression pattern and phenotypic traits. We anticipate that systematic studies of these candidate genes identified from zebrafish will significantly advance our understanding of pathophysiology of SSS.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Animals</title><p>All experiments were conducted in accordance with the Guidelines for the Care and Use of Laboratory Animals published by the US National Institutes of Health (publication No. 85–23, revised 1996). All animal procedures and protocols used in these studies (for zebrafish, #: A00005409-20; for mouse, #: A00003511-20 and M005490-R02) have been approved by the Mayo Clinic Institutional Animal Care and Use Committee (Permit number: D16-00187) and by the Animal Care and Use Committee of University of Wisconsin-Madison (Permit number: D16-00239). The zebrafish (<italic>Danio rerio</italic>) WIK line was maintained under a 14 hr light/10 hr dark cycle at 28.5 °C. All GBT lines were generated previously <xref ref-type="bibr" rid="bib8">Clark et al., 2011</xref>; <xref ref-type="bibr" rid="bib26">Ichino et al., 2020</xref>; <xref ref-type="bibr" rid="bib11">Ding et al., 2013</xref>. The <italic>Dnajb6</italic> knockout (KO) mice, originally named <italic>Dnajb6<sup>tm1.1(KOMP)Vlcg</sup>,</italic> were generated from the Jackson Laboratory (Original catalog #018623). Briefly, the insertion of Velocigene cassette ZEN-Ub1 created a deletion sized 36,843 bp nucleotides spanning from the first to the last intron of the <italic>Dnajb6</italic> gene at the Chromosome 5 (Genome Build37) of the C57BL/6 N mice. The mouse was subsequently bred to a ubiquitous Cre deletion mouse line for recombination of the LoxP sites that excised the neomycin selection cassette. The following genotyping PCR primers for the <italic>Dnajb6</italic> mutant mice were used: mutant primer F2, 5’-<named-content content-type="sequence">AAACTGCGCACTGTACCACC</named-content>-3’ and mutant primer R2, 5’-<named-content content-type="sequence">CGGTCGCTACCATTACCAGT</named-content>-3’ for detecting the mutant allele (predicted size of 700 bp); and WT primer F1, 5’-<named-content content-type="sequence">TACTCCAGCCCCACTCTTACTC</named-content>-3’ and WT primer R1, 5’- <named-content content-type="sequence">ACTGCCCATCTTCTTCAACTTC</named-content>-3’ for detecting the WT allele (predicted size of 300 bp).</p></sec><sec id="s4-2"><title>Enrichment and cloning of 35 ZIC mutants</title><p>Zebrafish cardiac insertional (ZIC) mutants were identified and collected based on the mRFP expression in the embryonic heart from 2 to 4 days post-fertilization (dpf) and/or in the dissected adult heart at 6 months to 1 year of age. All ZIC lines, each with a single copy of GBT insertion, were obtained after 2–4 generations of outcrosses, guided by Southern blotting using the <italic>GFP</italic> probe primed to the GBT vector <xref ref-type="bibr" rid="bib11">Ding et al., 2013</xref>. A combination of three different methods including Inverse PCR, 5’-RACE and/or 3’-RACE were employed to clone the GBT transposon integration sites accordingly to previously published protocols <xref ref-type="bibr" rid="bib8">Clark et al., 2011</xref>; <xref ref-type="bibr" rid="bib26">Ichino et al., 2020</xref>; <xref ref-type="bibr" rid="bib11">Ding et al., 2013</xref>. A combination of gene-specific primers flanking the GBT integration site coupled with GBT vector-specific primer were used for genotyping PCR to identify homozygous mutants for the three candidate ZIC including <italic>GBT103/cyth3a</italic>, <italic>GBT410/vapal,</italic> and <italic>GBT411/dnajb6b</italic> lines using genomic DNA isolated from tail fins <xref ref-type="bibr" rid="bib8">Clark et al., 2011</xref>; <xref ref-type="bibr" rid="bib26">Ichino et al., 2020</xref>; <xref ref-type="bibr" rid="bib11">Ding et al., 2013</xref>.</p></sec><sec id="s4-3"><title>Zebrafish electrocardiogram (ECG)</title><p>Microsurgery was operated under a dissection microscope to remove the silvery epithelial layer of the hypodermis one week before fish were subjected to the ECG <xref ref-type="bibr" rid="bib74">Yan et al., 2020</xref>. Fish were initially acclimated for 1 hr after transferred from the circulating fish facility to the laboratory bench, followed by anesthesia in the solution of pH 7.0 adjusted tricaine (MS-222, Sigma) at the concentration of 0.02% dissolved in E3 medium (containing 5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl<sub>2</sub>, and 0.33 mM MgSO<sub>4</sub>) for 6 min. Two minutes of ECG recording were then obtained with the ECG recording system, according to the instructions (ZS-200, iWorx Systems, Inc) and a recently published protocol <xref ref-type="bibr" rid="bib74">Yan et al., 2020</xref>. Initial ECG screens of ZIC heterozygous mutants were performed at 32 °C using a temperature-controlled chamber set-up, made by covering the ECG recording system with a foam box. 6 to 25 fish per ZIC line were initially analyzed, depending on the fish availability. The ECG machine was held on top of a heating plate controlled by a heating machine. The subsequent ECG validation in the homozygous mutants was performed at room temperature (25 °C). To analyze the ECG recording, ECG signals were amplified and filtered at 0.5 Hz high pass and 200 Hz low pass. ECG variables, including heart rate, PR interval, QRS duration, QT interval and R-wave amplitude, and PP and RR intervals were calculated using an in-house Matlab code <xref ref-type="bibr" rid="bib38">Lenning et al., 2017</xref>. A SA episode was defined in zebrafish when the PP interval is more than 1.5 s.</p></sec><sec id="s4-4"><title>Mouse ECG and echocardiography</title><p>Mouse echocardiography and ECG measurements were performed according to a previously published protocol with modifications <xref ref-type="bibr" rid="bib12">Ding et al., 2016</xref>; <xref ref-type="bibr" rid="bib14">Ding et al., 2020b</xref>. For ECG, mice were anesthetized with isoflurane (0.5%–1.0% v/v) via a nose cone. Mice were placed on an ECG-heater board with 4 paws on individual electrodes. The ECG-heater board maintained the body temperature at 37 °C. The ECG signal was amplified through an amplifier (Axon CNS digital 1440 A) and recorded using &gt; Chart 5 software. For each mouse, 10 min of ECG signal were recorded. Series of ECG parameters, including heart rate, PR interval, QRS duration, QT interval and RR interval were calculated by an in-house Matlab code <xref ref-type="bibr" rid="bib38">Lenning et al., 2017</xref>. For echocardiography, mice were anesthetized under light isoflurane (0.5%–1.0% v/v) administered via a nose cone. Echocardiography gel was placed on the shaved chest, and the mouse heart was imaged with a 13-MHz probe using two-dimensional echocardiography (GE Healthcare). All measurements were made by an independent operator to whom the study groups were masked.</p></sec><sec id="s4-5"><title>Administration of autonomic response drugs</title><p>For zebrafish, 0.6 µg/g isoproterenol (Millipore Sigma, Cat# 1351005), 4 µg/g atropine (Millipore Sigma, Cat# A0132), and 0.3 µg/g carbachol (Millipore Sigma, cat# C4382) were administrated via intraperitoneal injection. For in vivo mouse studies, 0.2 mg/kg isoproterenol, 1 mg/kg atropine, and 0.3 mg/kg carbachol was injected intraperitoneally. For ex vivo mouse atrial studies, 100 nM isoproterenol, 2 µM atropine, and 300 nM carbachol was administered via superfusion for 10–20 min.</p></sec><sec id="s4-6"><title>Antibody immunostaining</title><p>Heart samples harvested from mouse SAN tissues were embedded in a tissue freezing medium, followed by sectioning at 10 μm using a cryostat (Leica CM3050 S). The slides were subjected to immunostaining using a previously described protocol <xref ref-type="bibr" rid="bib66">Sun et al., 2009</xref>. The following antibodies were used: anti-HCN4 (Millipore, Cat#: AB5805; Novus biologicals, Cat#: NB100-74439) at 1:200, anti-DNAJB6 (Novus, Cat#: H00010049-M0; Santa Cruz Biotechnology Inc, Cat#: sc-104204) at 1:200, anti-TBX3 (abcam, Cat#: ab99302). All images were captured either using a Zeiss Axioplan II microscope equipped with ApoTome and AxioVision software (Carl Zeiss Microscopy) or a Zeiss LSM 780 confocal microscope. Signal intensity from DNAJB6 and TBX3 antibodies immunostaining was quantified using Zen 2.3 Pro software.</p></sec><sec id="s4-7"><title>Western blotting</title><p>For Western blotting, mice embryonic hearts at E12.5 stage were dissected after genotyping PCR using genomic DNA isolated from tail and transferred to RIPA lysis buffer supplemented with complete protease inhibitor cocktail for homogenization. About 1 µg resultant protein lysates were subject to western blotting using a standard protocol. The following primary antibodies were used: anti-Gapdh (1:4000, Santa Cruz Biotechnology Inc, Cat#: sc-25778); anti-DNAJB6 (1:6000, abcam, Cat#: 198995).</p></sec><sec id="s4-8"><title>Isolated mouse atrial preparations</title><p>The mouse atrial preparation was performed as previously described <xref ref-type="bibr" rid="bib18">Glukhov et al., 2015</xref>. After the mice were anesthetized with isoflurane, a mid-sternal incision was applied. The heart was then removed and cannulated to a custom made 21-gauge cannula. The heart was then perfused and superfused with oxygenated (95% O<sub>2</sub>, 5% CO<sub>2</sub>), 37 °C modified Tyrode solution (in mM: 128.2 NaCl, 4.7 KCl, 1.19 NaH<sub>2</sub>PO<sub>4</sub>, 1.05 MgCl<sub>2</sub>, 1.3 CaCl<sub>2</sub>, 20.0 NaHCO<sub>3</sub>, and 11.1 glucose; pH = 7.35 ± 0.05). Lung, thymus, and fat tissue was then removed. Perfusion was maintained under constant aortic pressure of 60–80 mmHg. After 10 min stabilization, the ventricles were dissected. The atrial were cut open as previously described <xref ref-type="bibr" rid="bib35">Lang and Glukhov, 2016</xref>. The medial limb of the crista terminalis was cut to open right atrial appendage. The preparation was superfused with Tyrode solution at a constant rate of ~15 ml/min.</p></sec><sec id="s4-9"><title>Optical mapping</title><p>High spatial (100x100 pixels, 60±10 μm per pixel) and temporal (1,000–3,000 frames/sec) resolution optical mapping of electrical activity was applied on the isolated mouse atrial preparations as previously described <xref ref-type="bibr" rid="bib35">Lang and Glukhov, 2016</xref>; <xref ref-type="bibr" rid="bib34">Lang et al., 2011</xref>. The isolated mouse atrial preparations were coronary and surface stained with voltage-sensitive dye RH-237 (1.25 mg/ml in dimethyl sulfoxide ThermoFisher Scientific, USA). Blebbistatin (10 μM, Tocris Bioscience, USA) was then applied to reduce the motion artifact. A 150 W halogen lamp (MHAB-150W, Moritex USA Inc, CA, USA) with band pass filter (530/40 nm) was used as excitation light source. The fluorescent light emitted from the preparation was recorded by a MiCAM Ultima-L camera (SciMedia, CA, USA) after a long-pass filter (&gt;650 nm). The acquired fluorescent signal was digitized, amplified, and visualized using custom software (SciMedia, CA, USA). After 20–30 min stabilization, activation map was collected during baseline spontaneous rhythm. To estimate the pacemaker location and a possible pacemaker shift during autonomic stimulation, the originations of action potentials were plotted with orthogonal axes crossing at the inferior vena cava. The superior to inferior direction is along the ordinate. The lateral to media direction is along the abscissa. SAN recovery time (SANRT) was measured as the time-period between the last S1S1 pacing (10 Hz) beat and the first spontaneous beat. Corrected SANRT (SANRTc) was calculated as the difference between the SANRT and the resting cycle length measure before the SANRT pacing protocol. After baseline measurement, 100 nM isoproterenol was applied. Recordings were collected after 10 min which allows the stimulation to reach steady-state effect. Complete washout was then performed which is characterized by the recovery of the heart rate back to baseline values. Additional staining and blebbistatin was applied as needed. 300 nM carbachol then was applied. 2 µM atropine was used after protocols completed during carbachol stimulation.</p></sec><sec id="s4-10"><title>RNA-seq data collection and analysis</title><p>Total RNA was extracted from the right atrium (RA) tissues of 1-year-old <italic>Dnajb6<sup>+/-</sup></italic> heterozygous mutant hearts and WT sibling controls. Six total samples ( +/- biological replicates for each genotype) were submitted for RNA sequencing (Azenta Life Science, NJ). Genes were considered to be differentially expressed between the two groups if they exhibited a greater than twofold change and an FDR of less than 0.05 according to the DESeq approach <xref ref-type="bibr" rid="bib45">Love et al., 2014</xref>. Unsupervised hierarchical clustering was performed with Pearson correlation and scaled based on the fragments per kilobase of transcript per million mapped reads (FPKM) value using the pheatmap R package (<ext-link ext-link-type="uri" xlink:href="https://github.com/raivokolde/pheatmap">https://github.com/raivokolde/pheatmap</ext-link>; <xref ref-type="bibr" rid="bib32">Kolde et al., 2018</xref> <xref ref-type="bibr" rid="bib58">R Development Core Team, 2022</xref>). The gene lists of interest were annotated by IPA (QIAGEN) (<ext-link ext-link-type="uri" xlink:href="http://www.ingenuity.com/">http://www.ingenuity.com/</ext-link>). We queried the IPA with the gene list of interest to map and generate putative biological processes/functions, networks, and pathways based on the manually curated knowledge database of molecular interactions extracted from the public literature. The enriched pathways and gene networks were generated using both direct and indirect relationships/connectivity. These pathways and networks were ranked by their enrichment score, which measures the probability that the genes were included in a network by chance.</p></sec><sec id="s4-11"><title>Quantitative reverse transcription (RT) PCR</title><p>Total RNA was extracted from ~2 mg of right atrium (RA) tissues of 1-year-old <italic>Dnajb6<sup>+/-</sup></italic> heterozygous mutant hearts and WT sibling controls using Trizol reagent (ThermoFisher Scientific) following the manufacturer’s instruction. Approximately+/- µg total RNA was used for reverse transcription (RT) and cDNA synthesis using Superscript III First-Strand Synthesis System (ThermoFisher Scientific). Real-time quantitative RT-PCR was run in 96-well optical plates (ThermoFisher Scientific) using an Applied Biosystem VAii 7 System (ThermoFisher Scientific). Gene expression levels were normalized using the expression level of glyceraldehyde 3-phosphate dehydrogenase (<italic>gapdh</italic>) by –ΔΔCt (cycle threshold) values. All quantitative RT-PCR primer sequences were listed in <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>.</p></sec><sec id="s4-12"><title>Histology</title><p>For H&amp;E and Masson’s trichrome staining of <italic>Dnajb6<sup>+/-</sup></italic> mice left ventricle, mouse hearts were dissected and harvested after mice were euthanized by administration of high-dose (5%) isoflurane anesthesia and after ventilation was ceased. Dissected mice hearts were immediately fixed in 4% PBS buffered formaldehyde overnight at 4 °C and sent to the Mayo Clinic Histology Core Laboratory for sample processing and H&amp;E staining.</p><p>For transmission electron microscopy (TEM) analysis, the left ventricle apexes of dissected hearts from either zebrafish or mice were fixed immediately in Trump’s solution (4% paraformaldehyde and 1% glutaraldehyde in 0.1 M phosphate buffer [pH 7.2]) at room temperature for 1 hr, followed by overnight incubation at 4 °C. Fixed samples were subsequently processed and imaged at the Mayo Clinic Electron Microscopy Core Facility using a Philips CM10 transmission electron microscope.</p><p>To quantify the amount of fibrosis in <italic>Dnajb6<sup>+/-</sup></italic> mouse atria, the isolated atrial preparations were fixed after optical mapping experiments overnight in +/-% paraformaldehyde buffered with 0.1 M sodium phosphate, pH 7.4; and then paraffin embedded. The preparations were sectioned parallel to the epicardial surface at 3–5 μm thickness. Tissue sections were mounted on Superfrost Plus glass slides (Fisher Scientific, Pittsburgh, PA) and maintained at room temperature until use. Sections were stained for histology with Masson’s trichrome (International Medical Equipment, San Marcos, CA, USA) and Picrosirius Red (International Medical Equipment, San Marcos, CA, USA). The density of fibrosis was estimated as a ratio of cardiac tissue to connective tissue measured at different transmural layers, quantified using ImageJ (National Institutes of Health) as previously described <xref ref-type="bibr" rid="bib18">Glukhov et al., 2015</xref>.</p></sec><sec id="s4-13"><title>Computational modeling</title><p>To investigate the cellular mechanisms underlying the SSS phenotype, we used our model of the mouse SAN myocyte, <xref ref-type="bibr" rid="bib53">Morotti et al., 2021</xref> based on the original model, <xref ref-type="bibr" rid="bib28">Kharche et al., 2011</xref> and including the formulation of the acetylcholine-activated K<sup>+</sup> current developed by Arbel-Ganon et al. to simulate carbachol administration <xref ref-type="bibr" rid="bib3">Arbel-Ganon et al., 2020</xref>. Functional effects of isoproterenol administration on ion channels and transporters (listed in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>) were simulated as in the parent model, <xref ref-type="bibr" rid="bib28">Kharche et al., 2011</xref> wherein properties of isoproterenol-dependent modulation of voltage-gated Ca<sup>2+</sup> currents and funny current <italic>I</italic><sub>f</sub> were updated to reflect experimental observations in mice <xref ref-type="bibr" rid="bib37">Larson et al., 2013</xref>; <xref ref-type="bibr" rid="bib56">Peters et al., 2021</xref>. Using an established approach, <xref ref-type="bibr" rid="bib65">Sobie, 2009</xref> we randomly varying selected model parameters describing maximum ion channel conductances and ion transport rates (defined in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>) to generate a population of 10,000 model variants. For each variant, the baseline value of each parameter was independently varied with a log-normal distribution (σ=0.26). We assessed the steady-state firing rate in each model in the population at baseline, and upon stimulation with either isoproterenol or carbachol. Model variants showing non-physiological behavior (e.g., lack of firing activity) at baseline or in response to autonomic stimulation were discarded from subsequent analysis. We separated the population of models in two subpopulations mimicking the WT and <italic>Dnajb6<sup>+/-</sup></italic> mice phenotypes. Namely, we extracted the model variants that recapitulate changes observed in <italic>Dnajb6<sup>+/-</sup></italic> vs. WT mice, including a slower firing rate at baseline, an increased response to isoproterenol, and a diminished response to carbachol administration . We analyzed the parameter value differences in these two subgroups to reveal several ionic processes that are significantly correlated with the observed electrophysiological changes. The nonparametric two-sided Wilcoxon rank sum test was used to compare the two groups and p value less than 0.05 was considered statistically significant. All the codes used to perform in silico simulations were generated in MATLAB (MathWorks, Natick, MA, USA) and are freely available for download at <ext-link ext-link-type="uri" xlink:href="http://elegrandi.wixsite.com/grandilab/downloads">http://elegrandi.wixsite.com/grandilab/downloads</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://github.com/drgrandilab/Ding-et-al-2022-mouse-sinoatrial-model">https://github.com/drgrandilab/Ding-et-al-2022-mouse-sinoatrial-model</ext-link>; <xref ref-type="bibr" rid="bib19">Grandi Lab, 2022</xref> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:935e8c88c1b0ac2ad0d171f66cf5558d61928e28;origin=https://github.com/drgrandilab/Ding-et-al-2022-mouse-sinoatrial-model;visit=swh:1:snp:9adb37f4dc40875d013d44c701f56e4fa7da91e4;anchor=swh:1:rev:9ffd9fee426ef9e4b26826b4b8700a93821ba9ab">swh:1:rev:9ffd9fee426ef9e4b26826b4b8700a93821ba9ab</ext-link>).</p></sec><sec id="s4-14"><title>Statistics</title><p>No sample sizes were calculated before performing the experiments. No animals were excluded for analysis. Unpaired two-tailed student’s <italic>t</italic>-test was used to compare two groups. One-way Analysis of Variance (ANOVA) or Kruskal-Wallis test followed by post hoc Tukey’s test was used for comparing three and more groups. Chi-square test was used for rate comparison. p Values less than 0.05 was considered statistically significant. For dot plot graphs, values are displayed as mean ± standard deviation (SD). Sample size (N) represents animal number, otherwise specifically designated as biological or technical replicates. All statistical analyses were conducted with the Graphpad Prism 7 and/or R Statistical Software Version 3.6.1.</p></sec><sec id="s4-15"><title>Availability of the materials and resources</title><p>All reagents are available upon reasonable request. Zebrafish GBT mutant lines are available either from the Zebrafish International Recourse Center (ZIRC, <ext-link ext-link-type="uri" xlink:href="http://zebrafish.org">http://zebrafish.org</ext-link>) or the Mayo Clinic Zebrafish Facility, respectively. Both RNAseq raw data and processed data are deposited to GEO (Access number GSE195953) associated with the token: kvmhesayzryljop. The code of our computational model of the mouse SAN myocyte is freely available for download at <ext-link ext-link-type="uri" xlink:href="http://elegrandi.wixsite.com/grandilab/downloads">http://elegrandi.wixsite.com/grandilab/downloads</ext-link> and<ext-link ext-link-type="uri" xlink:href="https://github.com/drgrandilab/Ding-et-al-2022-mouse-sinoatrial-model">https://github.com/drgrandilab/Ding-et-al-2022-mouse-sinoatrial-model</ext-link>.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>Reviewing editor, <italic>eLife</italic></p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Validation, Investigation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Resources, Data curation, Formal analysis, Funding acquisition, Investigation, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Resources, Software, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Resources, Data curation, Software, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Resources, Data curation, Software, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Resources, Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Resources, Data curation, Software, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Resources, Data curation, Software</p></fn><fn fn-type="con" id="con9"><p>Resources, Data curation, Software, Investigation, Methodology</p></fn><fn fn-type="con" id="con10"><p>Resources, Software, Investigation, Methodology</p></fn><fn fn-type="con" id="con11"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con12"><p>Data curation, Methodology</p></fn><fn fn-type="con" id="con13"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con14"><p>Resources, Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con15"><p>Resources, Data curation, Software, Formal analysis</p></fn><fn fn-type="con" id="con16"><p>Conceptualization, Investigation</p></fn><fn fn-type="con" id="con17"><p>Supervision, Investigation</p></fn><fn fn-type="con" id="con18"><p>Data curation, Software, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con19"><p>Supervision, Investigation</p></fn><fn fn-type="con" id="con20"><p>Resources, Supervision, Funding acquisition, Writing - review and editing</p></fn><fn fn-type="con" id="con21"><p>Resources, Data curation, Formal analysis, Funding acquisition, Investigation, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con22"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All experiments were conducted in accordance with the Guidelines for the Care and Use of Laboratory Animals published by the US National Institutes of Health (publication No. 85-23, revised 1996). All animal procedures and protocols used in these studies (for zebrafish, #: A00005409-20; for mouse, #: A00003511-20 and M005490-R02) have been approved by the Mayo Clinic Institutional Animal Care and Use Committee (Permit number: D16-00187) and by the Animal Care and Use Committee of University of Wisconsin-Madison (Permit number: D16-00239).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>ECG quantification of <italic>GBT411<sup>-/-</sup></italic> mutant at 10 months of age.</title><p>SA, sinus arrest. epm, episode per minute. bpm, beats per minute. N=8–9. *, <italic>P</italic>&lt;0.05, data are expressed as mean ± SEM. For SA incidence comparison, Chi-square test. For heart rate comparison, unpaired student <italic>t-</italic>test.</p></caption><media xlink:href="elife-77327-supp1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>ECG quantification of <italic>GBT411<sup>-/-</sup></italic> mutant at 16 months of age.</title><p>N=8. *, <italic>P</italic>&lt;0.05, data are expressed as mean ± SEM.</p></caption><media xlink:href="elife-77327-supp2-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>ECG quantification of <italic>Dnajb6<sup>+/-</sup></italic> mice at 6 months of age.</title><p>bpm, beats per minute. N=8 *, <italic>P</italic>&lt;0.05, unpaired student’s <italic>t-</italic>test.</p></caption><media xlink:href="elife-77327-supp3-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Variants in <italic>DNAJB6</italic> associated with sick sinus syndrome with <italic>P</italic>&lt;0.05.</title><p><sup>a</sup>The effect that the variant has on each feature that it overlaps. <sup>b</sup>A subjective classification of the severity of the variant consequence, based on agreement with SNPEff. SNP, single nucleotide polymorphism; MAF minor allele frequency; A1, minor allele; A2, major; OR, odds ratio; SE, standard error; info, information metric (info score).</p></caption><media xlink:href="elife-77327-supp4-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Quantitative RT-PCR primers used to validate differentially expressed (DE) genes identified from RNAseq.</title></caption><media xlink:href="elife-77327-supp5-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Definition of model parameters and changes induced by isoproterenol (ISO) and carbachol (CCh) administration.</title></caption><media xlink:href="elife-77327-supp6-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-77327-transrepform1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided for Figure 4 and Figure 7.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Beninio Gores and Kashia Stragey for managing zebrafish facility and Ronald H May for murine echocardiography. This work was supported in part by Mayo Foundation to XX, grant from Science and Technology Innovation Action Plan of Shanghai, experimental animal research project 201409005600 to YGL, NIH GM063904 to SCE, NIH R01HL141214, American Heart Association 16SDG29120011, and the Wisconsin Partnership Program 4140 to AVG, American Heart Association 17POST33370089 and American Heart Association Career Development Award 846898 to DL, NIH R00HL138160 to SM, NIH R01HL131517, NIH P01HL141084 NIH Stimulating Peripheral Activity to Relieve Conditions Grant 1OT2OD026580-01, UC Davis School of Medicine Dean’s Fellow Award, and American Heart Association Scientist Development Award 15SDG24910015 to EG, and American Heart Association Postdoctoral Fellowship 20POST35120462 to HN, NIH R44OD024874 to TL and HC, NIH R01HL142704 to JW.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amsterdam</surname><given-names>A</given-names></name><name><surname>Burgess</surname><given-names>S</given-names></name><name><surname>Golling</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Townsend</surname><given-names>K</given-names></name><name><surname>Farrington</surname><given-names>S</given-names></name><name><surname>Haldi</surname><given-names>M</given-names></name><name><surname>Hopkins</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>A large-scale insertional mutagenesis screen in zebrafish</article-title><source>Genes &amp; Development</source><volume>13</volume><fpage>2713</fpage><lpage>2724</lpage><pub-id pub-id-type="doi">10.1101/gad.13.20.2713</pub-id><pub-id pub-id-type="pmid">10541557</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>JB</given-names></name><name><surname>Benson</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Genetics of sick sinus syndrome</article-title><source>Cardiac Electrophysiology Clinics</source><volume>2</volume><fpage>499</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1016/j.ccep.2010.09.001</pub-id><pub-id pub-id-type="pmid">21499520</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arbel-Ganon</surname><given-names>L</given-names></name><name><surname>Behar</surname><given-names>JA</given-names></name><name><surname>Gómez</surname><given-names>AM</given-names></name><name><surname>Yaniv</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Distinct mechanisms mediate pacemaker dysfunction associated with catecholaminergic polymorphic ventricular tachycardia mutations: insights from computational modeling</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>143</volume><fpage>85</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2020.04.017</pub-id><pub-id pub-id-type="pmid">32339564</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakker</surname><given-names>ML</given-names></name><name><surname>Boukens</surname><given-names>BJ</given-names></name><name><surname>Mommersteeg</surname><given-names>MTM</given-names></name><name><surname>Brons</surname><given-names>JF</given-names></name><name><surname>Wakker</surname><given-names>V</given-names></name><name><surname>Moorman</surname><given-names>AFM</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Transcription factor TBX3 is required for the specification of the atrioventricular conduction system</article-title><source>Circulation Research</source><volume>102</volume><fpage>1340</fpage><lpage>1349</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.107.169565</pub-id><pub-id pub-id-type="pmid">18467625</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakkers</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Zebrafish as a model to study cardiac development and human cardiac disease</article-title><source>Cardiovascular Research</source><volume>91</volume><fpage>279</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvr098</pub-id><pub-id pub-id-type="pmid">21602174</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boineau</surname><given-names>JP</given-names></name><name><surname>Canavan</surname><given-names>TE</given-names></name><name><surname>Schuessler</surname><given-names>RB</given-names></name><name><surname>Cain</surname><given-names>ME</given-names></name><name><surname>Corr</surname><given-names>PB</given-names></name><name><surname>Cox</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Demonstration of a widely distributed atrial pacemaker complex in the human heart</article-title><source>Circulation</source><volume>77</volume><fpage>1221</fpage><lpage>1237</lpage><pub-id pub-id-type="doi">10.1161/01.cir.77.6.1221</pub-id><pub-id pub-id-type="pmid">3370764</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyett</surname><given-names>MR</given-names></name><name><surname>Honjo</surname><given-names>H</given-names></name><name><surname>Kodama</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The sinoatrial node, a heterogeneous pacemaker structure</article-title><source>Cardiovascular Research</source><volume>47</volume><fpage>658</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1016/s0008-6363(00)00135-8</pub-id><pub-id pub-id-type="pmid">10974216</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>KJ</given-names></name><name><surname>Balciunas</surname><given-names>D</given-names></name><name><surname>Pogoda</surname><given-names>HM</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Westcot</surname><given-names>SE</given-names></name><name><surname>Bedell</surname><given-names>VM</given-names></name><name><surname>Greenwood</surname><given-names>TM</given-names></name><name><surname>Urban</surname><given-names>MD</given-names></name><name><surname>Skuster</surname><given-names>KJ</given-names></name><name><surname>Petzold</surname><given-names>AM</given-names></name><name><surname>Ni</surname><given-names>J</given-names></name><name><surname>Nielsen</surname><given-names>AL</given-names></name><name><surname>Patowary</surname><given-names>A</given-names></name><name><surname>Scaria</surname><given-names>V</given-names></name><name><surname>Sivasubbu</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Hammerschmidt</surname><given-names>M</given-names></name><name><surname>Ekker</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>In vivo protein trapping produces a functional expression Codex of the vertebrate proteome</article-title><source>Nature Methods</source><volume>8</volume><fpage>506</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1606</pub-id><pub-id pub-id-type="pmid">21552255</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dakkak</surname><given-names>W</given-names></name><name><surname>Doukky</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><source>Sick Sinus Syndrome StatPearls</source><publisher-name>National Library of Medicine</publisher-name></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Ponti</surname><given-names>R</given-names></name><name><surname>Marazzato</surname><given-names>J</given-names></name><name><surname>Bagliani</surname><given-names>G</given-names></name><name><surname>Leonelli</surname><given-names>FM</given-names></name><name><surname>Padeletti</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Sick sinus syndrome</article-title><source>Cardiac Electrophysiology Clinics</source><volume>10</volume><fpage>183</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/j.ccep.2018.02.002</pub-id><pub-id pub-id-type="pmid">29784479</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Jomok</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Clark</surname><given-names>KJ</given-names></name><name><surname>Zhong</surname><given-names>TP</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Ekker</surname><given-names>SC</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Trapping cardiac recessive mutants via expression-based insertional mutagenesis screening</article-title><source>Circulation Research</source><volume>112</volume><fpage>606</fpage><lpage>617</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.112.300603</pub-id><pub-id pub-id-type="pmid">23283723</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Long</surname><given-names>PA</given-names></name><name><surname>Bos</surname><given-names>JM</given-names></name><name><surname>Shih</surname><given-names>YH</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Sundsbak</surname><given-names>RS</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Ackerman</surname><given-names>MJ</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Ekker</surname><given-names>SC</given-names></name><name><surname>Redfield</surname><given-names>MM</given-names></name><name><surname>Olson</surname><given-names>TM</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A modifier screen identifies DNAJB6 as a cardiomyopathy susceptibility gene</article-title><source>JCI Insight</source><volume>1</volume><elocation-id>e88797</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.88797</pub-id><pub-id pub-id-type="pmid">27642634</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Bu</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Modeling inherited cardiomyopathies in adult zebrafish for precision medicine</article-title><source>Frontiers in Physiology</source><volume>11</volume><elocation-id>599244</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2020.599244</pub-id><pub-id pub-id-type="pmid">33329049</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Lu</surname><given-names>T</given-names></name><name><surname>Jiao</surname><given-names>K</given-names></name><name><surname>Tester</surname><given-names>DJ</given-names></name><name><surname>Giudicessi</surname><given-names>JR</given-names></name><name><surname>Jiang</surname><given-names>K</given-names></name><name><surname>Ackerman</surname><given-names>MJ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>DW</given-names></name><name><surname>Lee</surname><given-names>HC</given-names></name><name><surname>Wang</surname><given-names>DW</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Knockout of SORBS2 protein disrupts the structural integrity of intercalated disc and manifests features of arrhythmogenic cardiomyopathy</article-title><source>Journal of the American Heart Association</source><volume>9</volume><elocation-id>e017055</elocation-id><pub-id pub-id-type="doi">10.1161/JAHA.119.017055</pub-id><pub-id pub-id-type="pmid">32808564</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobrzynski</surname><given-names>H</given-names></name><name><surname>Boyett</surname><given-names>MR</given-names></name><name><surname>Anderson</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>New insights into pacemaker activity: promoting understanding of sick sinus syndrome</article-title><source>Circulation</source><volume>115</volume><fpage>1921</fpage><lpage>1932</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.616011</pub-id><pub-id pub-id-type="pmid">17420362</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillis</surname><given-names>J</given-names></name><name><surname>Schipper-Krom</surname><given-names>S</given-names></name><name><surname>Juenemann</surname><given-names>K</given-names></name><name><surname>Gruber</surname><given-names>A</given-names></name><name><surname>Coolen</surname><given-names>S</given-names></name><name><surname>van den Nieuwendijk</surname><given-names>R</given-names></name><name><surname>van Veen</surname><given-names>H</given-names></name><name><surname>Overkleeft</surname><given-names>H</given-names></name><name><surname>Goedhart</surname><given-names>J</given-names></name><name><surname>Kampinga</surname><given-names>HH</given-names></name><name><surname>Reits</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides</article-title><source>The Journal of Biological Chemistry</source><volume>288</volume><fpage>17225</fpage><lpage>17237</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.421685</pub-id><pub-id pub-id-type="pmid">23612975</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glukhov</surname><given-names>AV</given-names></name><name><surname>Fedorov</surname><given-names>VV</given-names></name><name><surname>Anderson</surname><given-names>ME</given-names></name><name><surname>Mohler</surname><given-names>PJ</given-names></name><name><surname>Efimov</surname><given-names>IR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Functional anatomy of the murine sinus node: high-resolution optical mapping of ankyrin-B heterozygous mice</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>299</volume><fpage>H482</fpage><lpage>H491</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00756.2009</pub-id><pub-id pub-id-type="pmid">20525877</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glukhov</surname><given-names>AV</given-names></name><name><surname>Kalyanasundaram</surname><given-names>A</given-names></name><name><surname>Lou</surname><given-names>Q</given-names></name><name><surname>Hage</surname><given-names>LT</given-names></name><name><surname>Hansen</surname><given-names>BJ</given-names></name><name><surname>Belevych</surname><given-names>AE</given-names></name><name><surname>Mohler</surname><given-names>PJ</given-names></name><name><surname>Knollmann</surname><given-names>BC</given-names></name><name><surname>Periasamy</surname><given-names>M</given-names></name><name><surname>Györke</surname><given-names>S</given-names></name><name><surname>Fedorov</surname><given-names>VV</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Calsequestrin 2 deletion causes sinoatrial node dysfunction and atrial arrhythmias associated with altered sarcoplasmic reticulum calcium cycling and degenerative fibrosis within the mouse atrial pacemaker complex1</article-title><source>European Heart Journal</source><volume>36</volume><fpage>686</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/eht452</pub-id><pub-id pub-id-type="pmid">24216388</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="software"><person-group person-group-type="author"><collab>Grandi Lab</collab></person-group><year iso-8601-date="2022">2022</year><data-title>Ding-et-al-2022-mouse-sinoatrial-model</data-title><version designator="9ffd9fe">9ffd9fe</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/drgrandilab/Ding-et-al-2022-mouse-sinoatrial-model">https://github.com/drgrandilab/Ding-et-al-2022-mouse-sinoatrial-model</ext-link></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gut</surname><given-names>P</given-names></name><name><surname>Reischauer</surname><given-names>S</given-names></name><name><surname>Stainier</surname><given-names>DYR</given-names></name><name><surname>Arnaout</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Little fish, big data: zebrafish as a model for cardiovascular and metabolic disease</article-title><source>Physiological Reviews</source><volume>97</volume><fpage>889</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1152/physrev.00038.2016</pub-id><pub-id pub-id-type="pmid">28468832</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hageman</surname><given-names>J</given-names></name><name><surname>Rujano</surname><given-names>MA</given-names></name><name><surname>van Waarde</surname><given-names>MAWH</given-names></name><name><surname>Kakkar</surname><given-names>V</given-names></name><name><surname>Dirks</surname><given-names>RP</given-names></name><name><surname>Govorukhina</surname><given-names>N</given-names></name><name><surname>Oosterveld-Hut</surname><given-names>HMJ</given-names></name><name><surname>Lubsen</surname><given-names>NH</given-names></name><name><surname>Kampinga</surname><given-names>HH</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation</article-title><source>Molecular Cell</source><volume>37</volume><fpage>355</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.01.001</pub-id><pub-id pub-id-type="pmid">20159555</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holm</surname><given-names>H</given-names></name><name><surname>Gudbjartsson</surname><given-names>DF</given-names></name><name><surname>Sulem</surname><given-names>P</given-names></name><name><surname>Masson</surname><given-names>G</given-names></name><name><surname>Helgadottir</surname><given-names>HT</given-names></name><name><surname>Zanon</surname><given-names>C</given-names></name><name><surname>Magnusson</surname><given-names>OT</given-names></name><name><surname>Helgason</surname><given-names>A</given-names></name><name><surname>Saemundsdottir</surname><given-names>J</given-names></name><name><surname>Gylfason</surname><given-names>A</given-names></name><name><surname>Stefansdottir</surname><given-names>H</given-names></name><name><surname>Gretarsdottir</surname><given-names>S</given-names></name><name><surname>Matthiasson</surname><given-names>SE</given-names></name><name><surname>Thorgeirsson</surname><given-names>GM</given-names></name><name><surname>Jonasdottir</surname><given-names>A</given-names></name><name><surname>Sigurdsson</surname><given-names>A</given-names></name><name><surname>Stefansson</surname><given-names>H</given-names></name><name><surname>Werge</surname><given-names>T</given-names></name><name><surname>Rafnar</surname><given-names>T</given-names></name><name><surname>Kiemeney</surname><given-names>LA</given-names></name><name><surname>Parvez</surname><given-names>B</given-names></name><name><surname>Muhammad</surname><given-names>R</given-names></name><name><surname>Roden</surname><given-names>DM</given-names></name><name><surname>Darbar</surname><given-names>D</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Walters</surname><given-names>GB</given-names></name><name><surname>Kong</surname><given-names>A</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Arnar</surname><given-names>DO</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A rare variant in MYH6 is associated with high risk of sick sinus syndrome</article-title><source>Nature Genetics</source><volume>43</volume><fpage>316</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1038/ng.781</pub-id><pub-id pub-id-type="pmid">21378987</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honjo</surname><given-names>H</given-names></name><name><surname>Boyett</surname><given-names>MR</given-names></name><name><surname>Kodama</surname><given-names>I</given-names></name><name><surname>Toyama</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Correlation between electrical activity and the size of rabbit sino-atrial node cells</article-title><source>The Journal of Physiology</source><volume>496 (Pt 3)</volume><fpage>795</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1996.sp021728</pub-id><pub-id pub-id-type="pmid">8930845</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoogaars</surname><given-names>WMH</given-names></name><name><surname>Engel</surname><given-names>A</given-names></name><name><surname>Brons</surname><given-names>JF</given-names></name><name><surname>Verkerk</surname><given-names>AO</given-names></name><name><surname>de Lange</surname><given-names>FJ</given-names></name><name><surname>Wong</surname><given-names>LYE</given-names></name><name><surname>Bakker</surname><given-names>ML</given-names></name><name><surname>Clout</surname><given-names>DE</given-names></name><name><surname>Wakker</surname><given-names>V</given-names></name><name><surname>Barnett</surname><given-names>P</given-names></name><name><surname>Ravesloot</surname><given-names>JH</given-names></name><name><surname>Moorman</surname><given-names>AFM</given-names></name><name><surname>Verheijck</surname><given-names>EE</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>TBX3 controls the sinoatrial node gene program and imposes pacemaker function on the atria</article-title><source>Genes &amp; Development</source><volume>21</volume><fpage>1098</fpage><lpage>1112</lpage><pub-id pub-id-type="doi">10.1101/gad.416007</pub-id><pub-id pub-id-type="pmid">17473172</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>PJ</given-names></name><name><surname>Swanson</surname><given-names>BJ</given-names></name><name><surname>Haendel</surname><given-names>MA</given-names></name><name><surname>Lyons</surname><given-names>GE</given-names></name><name><surname>Cross</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Mrj encodes a dnaj-related co-chaperone that is essential for murine placental development</article-title><source>Development</source><volume>126</volume><fpage>1247</fpage><lpage>1258</lpage><pub-id pub-id-type="doi">10.1242/dev.126.6.1247</pub-id><pub-id pub-id-type="pmid">10021343</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichino</surname><given-names>N</given-names></name><name><surname>Serres</surname><given-names>MR</given-names></name><name><surname>Urban</surname><given-names>RM</given-names></name><name><surname>Urban</surname><given-names>MD</given-names></name><name><surname>Treichel</surname><given-names>AJ</given-names></name><name><surname>Schaefbauer</surname><given-names>KJ</given-names></name><name><surname>Tallant</surname><given-names>LE</given-names></name><name><surname>Varshney</surname><given-names>GK</given-names></name><name><surname>Skuster</surname><given-names>KJ</given-names></name><name><surname>McNulty</surname><given-names>MS</given-names></name><name><surname>Daby</surname><given-names>CL</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Liao</surname><given-names>H-K</given-names></name><name><surname>El-Rass</surname><given-names>S</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Anderson</surname><given-names>JL</given-names></name><name><surname>Wishman</surname><given-names>MD</given-names></name><name><surname>Sabharwal</surname><given-names>A</given-names></name><name><surname>Schimmenti</surname><given-names>LA</given-names></name><name><surname>Sivasubbu</surname><given-names>S</given-names></name><name><surname>Balciunas</surname><given-names>D</given-names></name><name><surname>Hammerschmidt</surname><given-names>M</given-names></name><name><surname>Farber</surname><given-names>SA</given-names></name><name><surname>Wen</surname><given-names>X-Y</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>McGrail</surname><given-names>M</given-names></name><name><surname>Essner</surname><given-names>JJ</given-names></name><name><surname>Burgess</surname><given-names>SM</given-names></name><name><surname>Clark</surname><given-names>KJ</given-names></name><name><surname>Ekker</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Building the vertebrate Codex using the gene breaking protein trap library</article-title><source>eLife</source><volume>9</volume><elocation-id>e54572</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.54572</pub-id><pub-id pub-id-type="pmid">32779569</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamp</surname><given-names>A</given-names></name><name><surname>Peterson</surname><given-names>MA</given-names></name><name><surname>Svenson</surname><given-names>KL</given-names></name><name><surname>Bjork</surname><given-names>BC</given-names></name><name><surname>Hentges</surname><given-names>KE</given-names></name><name><surname>Rajapaksha</surname><given-names>TW</given-names></name><name><surname>Moran</surname><given-names>J</given-names></name><name><surname>Justice</surname><given-names>MJ</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name><name><surname>Beier</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Genome-Wide identification of mouse congenital heart disease loci</article-title><source>Human Molecular Genetics</source><volume>19</volume><fpage>3105</fpage><lpage>3113</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddq211</pub-id><pub-id pub-id-type="pmid">20511334</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kharche</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Lei</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A mathematical model of action potentials of mouse sinoatrial node cells with molecular bases</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>301</volume><fpage>H945</fpage><lpage>H963</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00143.2010</pub-id><pub-id pub-id-type="pmid">21724866</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khurshid</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Weng</surname><given-names>LC</given-names></name><name><surname>Wang</surname><given-names>EY</given-names></name><name><surname>Trinquart</surname><given-names>L</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name><name><surname>Lubitz</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Frequency of cardiac rhythm abnormalities in a half million adults</article-title><source>Circulation. Arrhythmia and Electrophysiology</source><volume>11</volume><elocation-id>e006273</elocation-id><pub-id pub-id-type="doi">10.1161/CIRCEP.118.006273</pub-id><pub-id pub-id-type="pmid">29954742</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MS</given-names></name><name><surname>Maltsev</surname><given-names>AV</given-names></name><name><surname>Monfredi</surname><given-names>O</given-names></name><name><surname>Maltseva</surname><given-names>LA</given-names></name><name><surname>Wirth</surname><given-names>A</given-names></name><name><surname>Florio</surname><given-names>MC</given-names></name><name><surname>Tsutsui</surname><given-names>K</given-names></name><name><surname>Riordon</surname><given-names>DR</given-names></name><name><surname>Parsons</surname><given-names>SP</given-names></name><name><surname>Tagirova</surname><given-names>S</given-names></name><name><surname>Ziman</surname><given-names>BD</given-names></name><name><surname>Stern</surname><given-names>MD</given-names></name><name><surname>Lakatta</surname><given-names>EG</given-names></name><name><surname>Maltsev</surname><given-names>VA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Heterogeneity of calcium clock functions in dormant, dysrhythmically and rhythmically firing single pacemaker cells isolated from SA node</article-title><source>Cell Calcium</source><volume>74</volume><fpage>168</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.ceca.2018.07.002</pub-id><pub-id pub-id-type="pmid">30092494</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kistler</surname><given-names>PM</given-names></name><name><surname>Roberts-Thomson</surname><given-names>KC</given-names></name><name><surname>Haqqani</surname><given-names>HM</given-names></name><name><surname>Fynn</surname><given-names>SP</given-names></name><name><surname>Singarayar</surname><given-names>S</given-names></name><name><surname>Vohra</surname><given-names>JK</given-names></name><name><surname>Morton</surname><given-names>JB</given-names></name><name><surname>Sparks</surname><given-names>PB</given-names></name><name><surname>Kalman</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin</article-title><source>Journal of the American College of Cardiology</source><volume>48</volume><fpage>1010</fpage><lpage>1017</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2006.03.058</pub-id><pub-id pub-id-type="pmid">16949495</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Kolde</surname><given-names>R</given-names></name><name><surname>Lizee</surname><given-names>A</given-names></name><collab>taunometsalu</collab></person-group><year iso-8601-date="2018">2018</year><data-title>Pheatmap</data-title><version designator="b333453">b333453</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/raivokolde/pheatmap">https://github.com/raivokolde/pheatmap</ext-link></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakatta</surname><given-names>EG</given-names></name><name><surname>Maltsev</surname><given-names>VA</given-names></name><name><surname>Vinogradova</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A coupled system of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart’s pacemaker</article-title><source>Circulation Research</source><volume>106</volume><fpage>659</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.206078</pub-id><pub-id pub-id-type="pmid">20203315</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>D</given-names></name><name><surname>Sulkin</surname><given-names>M</given-names></name><name><surname>Lou</surname><given-names>Q</given-names></name><name><surname>Efimov</surname><given-names>IR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Optical mapping of action potentials and calcium transients in the mouse heart</article-title><source>Journal of Visualized Experiments</source><volume>2011</volume><elocation-id>3275</elocation-id><pub-id pub-id-type="doi">10.3791/3275</pub-id><pub-id pub-id-type="pmid">21946907</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>D</given-names></name><name><surname>Glukhov</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>High-resolution optical mapping of the mouse sino-atrial node</article-title><source>Journal of Visualized Experiments</source><volume>1</volume><elocation-id>54773</elocation-id><pub-id pub-id-type="doi">10.3791/54773</pub-id><pub-id pub-id-type="pmid">28060289</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>D</given-names></name><name><surname>Glukhov</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cellular and molecular mechanisms of functional hierarchy of pacemaker clusters in the sinoatrial node: new insights into sick sinus syndrome</article-title><source>Journal of Cardiovascular Development and Disease</source><volume>8</volume><elocation-id>43</elocation-id><pub-id pub-id-type="doi">10.3390/jcdd8040043</pub-id><pub-id pub-id-type="pmid">33924321</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larson</surname><given-names>ED</given-names></name><name><surname>St Clair</surname><given-names>JR</given-names></name><name><surname>Sumner</surname><given-names>WA</given-names></name><name><surname>Bannister</surname><given-names>RA</given-names></name><name><surname>Proenza</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Depressed pacemaker activity of sinoatrial node myocytes contributes to the age-dependent decline in maximum heart rate</article-title><source>PNAS</source><volume>110</volume><fpage>18011</fpage><lpage>18016</lpage><pub-id pub-id-type="doi">10.1073/pnas.1308477110</pub-id><pub-id pub-id-type="pmid">24128759</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenning</surname><given-names>M</given-names></name><name><surname>Fortunato</surname><given-names>J</given-names></name><name><surname>Le</surname><given-names>T</given-names></name><name><surname>Clark</surname><given-names>I</given-names></name><name><surname>Sherpa</surname><given-names>A</given-names></name><name><surname>Yi</surname><given-names>S</given-names></name><name><surname>Hofsteen</surname><given-names>P</given-names></name><name><surname>Thamilarasu</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>HD</given-names></name><name><surname>Hsiai</surname><given-names>TK</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Real-time monitoring and analysis of zebrafish electrocardiogram with anomaly detection</article-title><source>Sensors</source><volume>18</volume><elocation-id>61</elocation-id><pub-id pub-id-type="doi">10.3390/s18010061</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Hansen</surname><given-names>BJ</given-names></name><name><surname>Csepe</surname><given-names>TA</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Ignozzi</surname><given-names>AJ</given-names></name><name><surname>Sul</surname><given-names>LV</given-names></name><name><surname>Zakharkin</surname><given-names>SO</given-names></name><name><surname>Kalyanasundaram</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>JP</given-names></name><name><surname>Biesiadecki</surname><given-names>BJ</given-names></name><name><surname>Kilic</surname><given-names>A</given-names></name><name><surname>Janssen</surname><given-names>PML</given-names></name><name><surname>Mohler</surname><given-names>PJ</given-names></name><name><surname>Weiss</surname><given-names>R</given-names></name><name><surname>Hummel</surname><given-names>JD</given-names></name><name><surname>Fedorov</surname><given-names>VV</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Redundant and diverse intranodal pacemakers and conduction pathways protect the human sinoatrial node from failure</article-title><source>Science Translational Medicine</source><volume>9</volume><elocation-id>eaam5607</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aam5607</pub-id><pub-id pub-id-type="pmid">28747516</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Kalyanasundaram</surname><given-names>A</given-names></name><name><surname>Hansen</surname><given-names>BJ</given-names></name><name><surname>Artiga</surname><given-names>EJ</given-names></name><name><surname>Sharma</surname><given-names>R</given-names></name><name><surname>Abudulwahed</surname><given-names>SH</given-names></name><name><surname>Helfrich</surname><given-names>KM</given-names></name><name><surname>Rozenberg</surname><given-names>G</given-names></name><name><surname>Wu</surname><given-names>PJ</given-names></name><name><surname>Zakharkin</surname><given-names>S</given-names></name><name><surname>Gyorke</surname><given-names>S</given-names></name><name><surname>Janssen</surname><given-names>PM</given-names></name><name><surname>Whitson</surname><given-names>BA</given-names></name><name><surname>Mokadam</surname><given-names>NA</given-names></name><name><surname>Biesiadecki</surname><given-names>BJ</given-names></name><name><surname>Accornero</surname><given-names>F</given-names></name><name><surname>Hummel</surname><given-names>JD</given-names></name><name><surname>Mohler</surname><given-names>PJ</given-names></name><name><surname>Dobrzynski</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Fedorov</surname><given-names>VV</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Impaired neuronal sodium channels cause intranodal conduction failure and reentrant arrhythmias in human sinoatrial node</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>512</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-14039-8</pub-id><pub-id pub-id-type="pmid">31980605</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>W</given-names></name><name><surname>Han</surname><given-names>P</given-names></name><name><surname>Kim</surname><given-names>EH</given-names></name><name><surname>Mak</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Torrente</surname><given-names>AG</given-names></name><name><surname>Goldhaber</surname><given-names>JI</given-names></name><name><surname>Marbán</surname><given-names>E</given-names></name><name><surname>Cho</surname><given-names>HC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Canonical wnt signaling promotes pacemaker cell specification of cardiac mesodermal cells derived from mouse and human embryonic stem cells</article-title><source>Stem Cells</source><volume>38</volume><fpage>352</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1002/stem.3106</pub-id><pub-id pub-id-type="pmid">31648393</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>D</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Geng</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Lv</surname><given-names>B</given-names></name><name><surname>Zeng</surname><given-names>Q</given-names></name><name><surname>Xiong</surname><given-names>K</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Xue</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cellular and molecular landscape of mammalian sinoatrial node revealed by single-cell RNA sequencing</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>287</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-20448-x</pub-id><pub-id pub-id-type="pmid">33436583</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Musunuru</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>From genotype to phenotype: a primer on the functional follow-up of genome-wide association studies in cardiovascular disease</article-title><source>Circulation. Genomic and Precision Medicine</source><volume>11</volume><elocation-id>e001946</elocation-id><pub-id pub-id-type="pmid">29915816</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Dobrzynski</surname><given-names>H</given-names></name><name><surname>Yanni</surname><given-names>J</given-names></name><name><surname>Boyett</surname><given-names>MR</given-names></name><name><surname>Lei</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Organisation of the mouse sinoatrial node: structure and expression of HCN channels</article-title><source>Cardiovascular Research</source><volume>73</volume><fpage>729</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2006.11.016</pub-id><pub-id pub-id-type="pmid">17222809</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-Seq data with deseq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>P</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Qiu</surname><given-names>Q</given-names></name><name><surname>Dvornikov</surname><given-names>AV</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Lowerison</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Norton</surname><given-names>N</given-names></name><name><surname>Herrmann</surname><given-names>J</given-names></name><name><surname>Ekker</surname><given-names>SC</given-names></name><name><surname>Hsiai</surname><given-names>TK</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity</article-title><source>Science Advances</source><volume>6</volume><elocation-id>aay2939</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aay2939</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangoni</surname><given-names>ME</given-names></name><name><surname>Nargeot</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Properties of the hyperpolarization-activated current (I (F)) in isolated mouse sino-atrial cells</article-title><source>Cardiovascular Research</source><volume>52</volume><fpage>51</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/s0008-6363(01)00370-4</pub-id><pub-id pub-id-type="pmid">11557233</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLaren</surname><given-names>W</given-names></name><name><surname>Gil</surname><given-names>L</given-names></name><name><surname>Hunt</surname><given-names>SE</given-names></name><name><surname>Riat</surname><given-names>HS</given-names></name><name><surname>Ritchie</surname><given-names>GRS</given-names></name><name><surname>Thormann</surname><given-names>A</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Cunningham</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Ensembl variant effect predictor</article-title><source>Genome Biology</source><volume>17</volume><elocation-id>122</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-016-0974-4</pub-id><pub-id pub-id-type="pmid">27268795</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohan</surname><given-names>RA</given-names></name><name><surname>Bosada</surname><given-names>FM</given-names></name><name><surname>van Weerd</surname><given-names>JH</given-names></name><name><surname>van Duijvenboden</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Mommersteeg</surname><given-names>MTM</given-names></name><name><surname>Hooijkaas</surname><given-names>IB</given-names></name><name><surname>Wakker</surname><given-names>V</given-names></name><name><surname>de Gier-de Vries</surname><given-names>C</given-names></name><name><surname>Coronel</surname><given-names>R</given-names></name><name><surname>Boink</surname><given-names>GJJ</given-names></name><name><surname>Bakkers</surname><given-names>J</given-names></name><name><surname>Barnett</surname><given-names>P</given-names></name><name><surname>Boukens</surname><given-names>BJ</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>T-box transcription factor 3 governs a transcriptional program for the function of the mouse atrioventricular conduction system</article-title><source>PNAS</source><volume>117</volume><fpage>18617</fpage><lpage>18626</lpage><pub-id pub-id-type="doi">10.1073/pnas.1919379117</pub-id><pub-id pub-id-type="pmid">32675240</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mond</surname><given-names>HG</given-names></name><name><surname>Proclemer</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009 -- a world Society of arrhythm’a's project</article-title><source>Pacing and Clinical Electrophysiology</source><volume>34</volume><fpage>1013</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.1111/j.1540-8159.2011.03150.x</pub-id><pub-id pub-id-type="pmid">21707667</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monfredi</surname><given-names>O</given-names></name><name><surname>Boyett</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Sick sinus syndrome and atrial fibrillation in older persons-a view from the sinoatrial nodal myocyte</article-title><source>Journal of Molecular and Cellular Cardiology</source><volume>83</volume><fpage>88</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2015.02.003</pub-id><pub-id pub-id-type="pmid">25668431</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monfredi</surname><given-names>O</given-names></name><name><surname>Tsutsui</surname><given-names>K</given-names></name><name><surname>Ziman</surname><given-names>B</given-names></name><name><surname>Stern</surname><given-names>MD</given-names></name><name><surname>Lakatta</surname><given-names>EG</given-names></name><name><surname>Maltsev</surname><given-names>VA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Electrophysiological heterogeneity of pacemaker cells in the rabbit intercaval region, including the SA node: insights from recording multiple ion currents in each cell</article-title><source>American Journal of Physiology. Heart and Circulatory Physiology</source><volume>314</volume><fpage>H403</fpage><lpage>H414</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00253.2016</pub-id><pub-id pub-id-type="pmid">28916636</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morotti</surname><given-names>S</given-names></name><name><surname>Ni</surname><given-names>H</given-names></name><name><surname>Peters</surname><given-names>CH</given-names></name><name><surname>Rickert</surname><given-names>C</given-names></name><name><surname>Asgari-Targhi</surname><given-names>A</given-names></name><name><surname>Sato</surname><given-names>D</given-names></name><name><surname>Glukhov</surname><given-names>AV</given-names></name><name><surname>Proenza</surname><given-names>C</given-names></name><name><surname>Grandi</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Intracellular na+ modulates pacemaking activity in murine sinoatrial node myocytes: an in silico analysis</article-title><source>International Journal of Molecular Sciences</source><volume>22</volume><elocation-id>5645</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22115645</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>GM</given-names></name><name><surname>D’Souza</surname><given-names>A</given-names></name><name><surname>Dobrzynski</surname><given-names>H</given-names></name><name><surname>Lei</surname><given-names>M</given-names></name><name><surname>Choudhury</surname><given-names>M</given-names></name><name><surname>Billeter</surname><given-names>R</given-names></name><name><surname>Kryukova</surname><given-names>Y</given-names></name><name><surname>Robinson</surname><given-names>RB</given-names></name><name><surname>Kingston</surname><given-names>PA</given-names></name><name><surname>Boyett</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Characterization of a right atrial subsidiary pacemaker and acceleration of the pacing rate by HCN over-expression</article-title><source>Cardiovascular Research</source><volume>100</volume><fpage>160</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvt164</pub-id><pub-id pub-id-type="pmid">23787003</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nof</surname><given-names>E</given-names></name><name><surname>Luria</surname><given-names>D</given-names></name><name><surname>Brass</surname><given-names>D</given-names></name><name><surname>Marek</surname><given-names>D</given-names></name><name><surname>Lahat</surname><given-names>H</given-names></name><name><surname>Reznik-Wolf</surname><given-names>H</given-names></name><name><surname>Pras</surname><given-names>E</given-names></name><name><surname>Dascal</surname><given-names>N</given-names></name><name><surname>Eldar</surname><given-names>M</given-names></name><name><surname>Glikson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia</article-title><source>Circulation</source><volume>116</volume><fpage>463</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.706887</pub-id><pub-id pub-id-type="pmid">17646576</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>CH</given-names></name><name><surname>Liu</surname><given-names>PW</given-names></name><name><surname>Morotti</surname><given-names>S</given-names></name><name><surname>Gantz</surname><given-names>SC</given-names></name><name><surname>Grandi</surname><given-names>E</given-names></name><name><surname>Bean</surname><given-names>BP</given-names></name><name><surname>Proenza</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Bidirectional flow of the funny current (IF) during the pacemaking cycle in murine sinoatrial node myocytes</article-title><source>PNAS</source><volume>118</volume><elocation-id>e2104668118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2104668118</pub-id><pub-id pub-id-type="pmid">34260402</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poon</surname><given-names>KL</given-names></name><name><surname>Liebling</surname><given-names>M</given-names></name><name><surname>Kondrychyn</surname><given-names>I</given-names></name><name><surname>Brand</surname><given-names>T</given-names></name><name><surname>Korzh</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Development of the cardiac conduction system in zebrafish</article-title><source>Gene Expression Patterns</source><volume>21</volume><fpage>89</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.gep.2016.08.003</pub-id><pub-id pub-id-type="pmid">27593944</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="software"><person-group person-group-type="author"><collab>R Development Core Team</collab></person-group><year iso-8601-date="2022">2022</year><data-title>R: A language and environment for statistical computing</data-title><version designator="2.6.2">2.6.2</version><publisher-loc>Vienna, Austria</publisher-loc><publisher-name>R Foundation for Statistical Computing</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>P</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Farah</surname><given-names>EN</given-names></name><name><surname>Bloomekatz</surname><given-names>J</given-names></name><name><surname>Zeng</surname><given-names>X-XI</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Swim</surname><given-names>MM</given-names></name><name><surname>Witty</surname><given-names>AD</given-names></name><name><surname>Knight</surname><given-names>HG</given-names></name><name><surname>Deshpande</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Yelon</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Chi</surname><given-names>NC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Canonical wnt5b signaling directs outlying nkx2.5+ mesoderm into pacemaker cardiomyocytes</article-title><source>Developmental Cell</source><volume>50</volume><fpage>729</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.07.014</pub-id><pub-id pub-id-type="pmid">31402282</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rozanski</surname><given-names>GJ</given-names></name><name><surname>Lipsius</surname><given-names>SL</given-names></name><name><surname>Randall</surname><given-names>WC</given-names></name><name><surname>Jones</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Alterations in subsidiary pacemaker function after prolonged subsidiary pacemaker dominance in the canine right atrium</article-title><source>Journal of the American College of Cardiology</source><volume>4</volume><fpage>535</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1016/s0735-1097(84)80098-4</pub-id><pub-id pub-id-type="pmid">6470333</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarparanta</surname><given-names>J</given-names></name><name><surname>Jonson</surname><given-names>PH</given-names></name><name><surname>Golzio</surname><given-names>C</given-names></name><name><surname>Sandell</surname><given-names>S</given-names></name><name><surname>Luque</surname><given-names>H</given-names></name><name><surname>Screen</surname><given-names>M</given-names></name><name><surname>McDonald</surname><given-names>K</given-names></name><name><surname>Stajich</surname><given-names>JM</given-names></name><name><surname>Mahjneh</surname><given-names>I</given-names></name><name><surname>Vihola</surname><given-names>A</given-names></name><name><surname>Raheem</surname><given-names>O</given-names></name><name><surname>Penttilä</surname><given-names>S</given-names></name><name><surname>Lehtinen</surname><given-names>S</given-names></name><name><surname>Huovinen</surname><given-names>S</given-names></name><name><surname>Palmio</surname><given-names>J</given-names></name><name><surname>Tasca</surname><given-names>G</given-names></name><name><surname>Ricci</surname><given-names>E</given-names></name><name><surname>Hackman</surname><given-names>P</given-names></name><name><surname>Hauser</surname><given-names>M</given-names></name><name><surname>Katsanis</surname><given-names>N</given-names></name><name><surname>Udd</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy</article-title><source>Nature Genetics</source><volume>44</volume><fpage>450</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1038/ng.1103</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulze-Bahr</surname><given-names>E</given-names></name><name><surname>Neu</surname><given-names>A</given-names></name><name><surname>Friederich</surname><given-names>P</given-names></name><name><surname>Kaupp</surname><given-names>UB</given-names></name><name><surname>Breithardt</surname><given-names>G</given-names></name><name><surname>Pongs</surname><given-names>O</given-names></name><name><surname>Isbrandt</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Pacemaker channel dysfunction in a patient with sinus node disease</article-title><source>The Journal of Clinical Investigation</source><volume>111</volume><fpage>1537</fpage><lpage>1545</lpage><pub-id pub-id-type="doi">10.1172/JCI16387</pub-id><pub-id pub-id-type="pmid">12750403</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semelka</surname><given-names>M</given-names></name><name><surname>Gera</surname><given-names>J</given-names></name><name><surname>Usman</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Sick sinus syndrome: a review</article-title><source>American Family Physician</source><volume>87</volume><fpage>691</fpage><lpage>696</lpage><pub-id pub-id-type="pmid">23939447</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Leatherbury</surname><given-names>L</given-names></name><name><surname>Rosenthal</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>Q</given-names></name><name><surname>Pappas</surname><given-names>MA</given-names></name><name><surname>Wessels</surname><given-names>A</given-names></name><name><surname>Lucas</surname><given-names>J</given-names></name><name><surname>Siegfried</surname><given-names>B</given-names></name><name><surname>Chatterjee</surname><given-names>B</given-names></name><name><surname>Svenson</surname><given-names>K</given-names></name><name><surname>Lo</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Cardiovascular phenotyping of fetal mice by noninvasive high-frequency ultrasound facilitates recovery of ENU-induced mutations causing congenital cardiac and extracardiac defects</article-title><source>Physiological Genomics</source><volume>24</volume><fpage>23</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1152/physiolgenomics.00129.2005</pub-id><pub-id pub-id-type="pmid">16174781</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobie</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Parameter sensitivity analysis in electrophysiological models using multivariable regression</article-title><source>Biophysical Journal</source><volume>96</volume><fpage>1264</fpage><lpage>1274</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2008.10.056</pub-id><pub-id pub-id-type="pmid">19217846</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Hoage</surname><given-names>T</given-names></name><name><surname>Bai</surname><given-names>P</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Jahangir</surname><given-names>A</given-names></name><name><surname>Paw</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>YG</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cardiac hypertrophy involves both myocyte hypertrophy and hyperplasia in anemic zebrafish</article-title><source>PLOS ONE</source><volume>4</volume><elocation-id>e6596</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0006596</pub-id><pub-id pub-id-type="pmid">19672293</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tam</surname><given-names>V</given-names></name><name><surname>Patel</surname><given-names>N</given-names></name><name><surname>Turcotte</surname><given-names>M</given-names></name><name><surname>Bossé</surname><given-names>Y</given-names></name><name><surname>Paré</surname><given-names>G</given-names></name><name><surname>Meyre</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Benefits and limitations of genome-wide association studies</article-title><source>Nature Reviews. Genetics</source><volume>20</volume><fpage>467</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1038/s41576-019-0127-1</pub-id><pub-id pub-id-type="pmid">31068683</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>HL</given-names></name><name><surname>Bink-Boelkens</surname><given-names>MT</given-names></name><name><surname>Bezzina</surname><given-names>CR</given-names></name><name><surname>Viswanathan</surname><given-names>PC</given-names></name><name><surname>Beaufort-Krol</surname><given-names>GC</given-names></name><name><surname>van Tintelen</surname><given-names>PJ</given-names></name><name><surname>van den Berg</surname><given-names>MP</given-names></name><name><surname>Wilde</surname><given-names>AA</given-names></name><name><surname>Balser</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A sodium-channel mutation causes isolated cardiac conduction disease</article-title><source>Nature</source><volume>409</volume><fpage>1043</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1038/35059090</pub-id><pub-id pub-id-type="pmid">11234013</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorolfsdottir</surname><given-names>RB</given-names></name><name><surname>Sveinbjornsson</surname><given-names>G</given-names></name><name><surname>Aegisdottir</surname><given-names>HM</given-names></name><name><surname>Benonisdottir</surname><given-names>S</given-names></name><name><surname>Stefansdottir</surname><given-names>L</given-names></name><name><surname>Ivarsdottir</surname><given-names>EV</given-names></name><name><surname>Halldorsson</surname><given-names>GH</given-names></name><name><surname>Sigurdsson</surname><given-names>JK</given-names></name><name><surname>Torp-Pedersen</surname><given-names>C</given-names></name><name><surname>Weeke</surname><given-names>PE</given-names></name><name><surname>Brunak</surname><given-names>S</given-names></name><name><surname>Westergaard</surname><given-names>D</given-names></name><name><surname>Pedersen</surname><given-names>OB</given-names></name><name><surname>Sorensen</surname><given-names>E</given-names></name><name><surname>Nielsen</surname><given-names>KR</given-names></name><name><surname>Burgdorf</surname><given-names>KS</given-names></name><name><surname>Banasik</surname><given-names>K</given-names></name><name><surname>Brumpton</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Oddsson</surname><given-names>A</given-names></name><name><surname>Tragante</surname><given-names>V</given-names></name><name><surname>Hjorleifsson</surname><given-names>KE</given-names></name><name><surname>Davidsson</surname><given-names>OB</given-names></name><name><surname>Rajamani</surname><given-names>S</given-names></name><name><surname>Jonsson</surname><given-names>S</given-names></name><name><surname>Torfason</surname><given-names>B</given-names></name><name><surname>Valgardsson</surname><given-names>AS</given-names></name><name><surname>Thorgeirsson</surname><given-names>G</given-names></name><name><surname>Frigge</surname><given-names>ML</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Norddahl</surname><given-names>GL</given-names></name><name><surname>Helgadottir</surname><given-names>A</given-names></name><name><surname>Gretarsdottir</surname><given-names>S</given-names></name><name><surname>Sulem</surname><given-names>P</given-names></name><name><surname>Jonsdottir</surname><given-names>I</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Hveem</surname><given-names>K</given-names></name><name><surname>Bundgaard</surname><given-names>H</given-names></name><name><surname>Ullum</surname><given-names>H</given-names></name><name><surname>Arnar</surname><given-names>DO</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Gudbjartsson</surname><given-names>DF</given-names></name><name><surname>Holm</surname><given-names>H</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><collab>DBDS Genomic Consortium</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Genetic insight into sick sinus syndrome</article-title><source>European Heart Journal</source><volume>42</volume><fpage>1959</fpage><lpage>1971</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehaa1108</pub-id><pub-id pub-id-type="pmid">33580673</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verheijck</surname><given-names>EE</given-names></name><name><surname>van Kempen</surname><given-names>MJ</given-names></name><name><surname>Veereschild</surname><given-names>M</given-names></name><name><surname>Lurvink</surname><given-names>J</given-names></name><name><surname>Jongsma</surname><given-names>HJ</given-names></name><name><surname>Bouman</surname><given-names>LN</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Electrophysiological features of the mouse sinoatrial node in relation to connexin distribution</article-title><source>Cardiovascular Research</source><volume>52</volume><fpage>40</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/s0008-6363(01)00364-9</pub-id><pub-id pub-id-type="pmid">11557232</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verkerk</surname><given-names>AO</given-names></name><name><surname>Wilders</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Pacemaker activity of the human sinoatrial node: an update on the effects of mutations in HCN4 on the hyperpolarization-activated current</article-title><source>International Journal of Molecular Sciences</source><volume>16</volume><fpage>3071</fpage><lpage>3094</lpage><pub-id pub-id-type="doi">10.3390/ijms16023071</pub-id><pub-id pub-id-type="pmid">25642760</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Jao</surname><given-names>LE</given-names></name><name><surname>Zheng</surname><given-names>N</given-names></name><name><surname>Dolan</surname><given-names>K</given-names></name><name><surname>Ivey</surname><given-names>J</given-names></name><name><surname>Zonies</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Meng</surname><given-names>Q</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Burgess</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Efficient genome-wide mutagenesis of zebrafish genes by retroviral insertions</article-title><source>PNAS</source><volume>104</volume><fpage>12428</fpage><lpage>12433</lpage><pub-id pub-id-type="doi">10.1073/pnas.0705502104</pub-id><pub-id pub-id-type="pmid">17640903</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilders</surname><given-names>R</given-names></name><name><surname>Verheijck</surname><given-names>EE</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Goolsby</surname><given-names>WN</given-names></name><name><surname>van Ginneken</surname><given-names>AC</given-names></name><name><surname>Joyner</surname><given-names>RW</given-names></name><name><surname>Jongsma</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Model clamp and its application to synchronization of rabbit sinoatrial node cells</article-title><source>The American Journal of Physiology</source><volume>271</volume><fpage>H2168</fpage><lpage>H2182</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.1996.271.5.H2168</pub-id><pub-id pub-id-type="pmid">8945938</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Bu</surname><given-names>H</given-names></name><name><surname>Jiao</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>AX</given-names></name><name><surname>Le</surname><given-names>T</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Barbuti</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Aging-Associated sinus arrest and sick sinus syndrome in adult zebrafish</article-title><source>PLOS ONE</source><volume>15</volume><elocation-id>e0232457</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0232457</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>YB</given-names></name><name><surname>Luo</surname><given-names>JW</given-names></name><name><surname>Jiang</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genetic analysis of sick sinus syndrome in a family harboring compound CACNA1C and TTN mutations</article-title><source>Molecular Medicine Reports</source><volume>17</volume><fpage>7073</fpage><lpage>7080</lpage><pub-id pub-id-type="doi">10.3892/mmr.2018.8773</pub-id><pub-id pub-id-type="pmid">29568937</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmerli</surname><given-names>D</given-names></name><name><surname>Borrelli</surname><given-names>C</given-names></name><name><surname>Jauregi-Miguel</surname><given-names>A</given-names></name><name><surname>Söderholm</surname><given-names>S</given-names></name><name><surname>Brütsch</surname><given-names>S</given-names></name><name><surname>Doumpas</surname><given-names>N</given-names></name><name><surname>Reichmuth</surname><given-names>J</given-names></name><name><surname>Murphy-Seiler</surname><given-names>F</given-names></name><name><surname>Aguet</surname><given-names>Mi</given-names></name><name><surname>Basler</surname><given-names>K</given-names></name><name><surname>Moor</surname><given-names>AE</given-names></name><name><surname>Cantù</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex</article-title><source>eLife</source><volume>9</volume><elocation-id>e58123</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.58123</pub-id><pub-id pub-id-type="pmid">32808927</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.77327.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Wenbiao</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02vm5rt34</institution-id><institution>Vanderbilt University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.01.25.477752" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.01.25.477752"/></front-stub><body><p>This study presents a valuable discovery of a gene important for the function of the cardiac pacemaker. The evidence is convincing as mutation in this gene causes sick sinus syndrome (SSS) in both zebrafish and mice, and potentially in humans. This manuscript is of interest to scientists in the field of cardiology, particular cardiac electrophysiology and arrhythmia.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.77327.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Chen</surname><given-names>Wenbiao</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02vm5rt34</institution-id><institution>Vanderbilt University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Chen</surname><given-names>Wenbiao</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02vm5rt34</institution-id><institution>Vanderbilt University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Collins</surname><given-names>Michelle</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/010x8gc63</institution-id><institution>University of Saskatchewan</institution></institution-wrap><country>Canada</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.01.25.477752">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.01.25.477752v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;A phenotype-based forward genetic screen identifies <italic>DNAJB6</italic> as a sick sinus syndrome gene&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Wenbiao Chen as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Didier Stainier as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Michelle Collins (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) The manuscript needs to include new experiments that address the mechanism by which loss or reduction of DNAJB6 causes SSS.</p><p>2) The manuscript needs to have a better characterization of Dnaj6b expression in the heart and to strengthen the claim that the arrhythmia is not due to cardiomyopathy/structural remodeling in both zebrafish and mice.</p><p>3) The manuscript needs to address evidence or lack of evidence for a role of DNAJ6B in SSS in humans.</p><p>4) The revision should include the suggested recommendations on data presentation and analysis.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>The first screen is not clearly described. While it is indicated that both heterozygous and homozygous carriers were screened, it appears that all phenotypic individuals were heterozygotes according to legend of Figure 1. Why no homozygotes were identified in the screen is not discussed. In the pilot screen, both SA and AVB were observed in the initial screen for GBT103. It is not made clear if they occur in the same individuals. In the homozygote screen, only SA incidence was assessed. It is unknown if there was no AVB or it was not assessed.</p><p>The RNAseq analysis was done in 1 year old mice. It is a stretch to link the observed changes in Wnt signaling pathway to developmental defects, which is also not supported by the histological data provided.</p><p>Since GWAS studies have been reported, can the authors find any evidence from these studies for a role of DNAJB6 in SSS?</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Overall, this manuscript presents some exciting findings that nicely illustrate the strength of the using adult ZIC lines in a phenotypic screen for a difficult disease to model in vivo. The following recommendations are suggested to strengthen the functional studies, as some of the conclusions in the manuscript are poorly supported.</p><p>1. The claim that the zebrafish and mouse models do not have cardiomyopathy/structural remodelling is not supported by the current data. At a minimum, histology and fibrotic markers should be included. This is also important given a previous report (Ding, JCI 2016) indicated cardiomegaly in the GBT411 line. As the DNAJB6-short isoform colocalizes to the sarcomere, it would be important to show how cardiac muscle appears in GBT411/DNAJB6b hets and mutants, as well as in the DNAJB6 het mouse heart.</p><p>2. Expression patterns in zebrafish should be more clearly visualized and discussed. For example, does the mRFP from GBT411/dnajb6b colocalize with sqET33-mi59B expression in the atrioventricular canal cells at 3 dpf (only the SAN is shown), or in the adult SAN cells (only AVC is shown)? Other markers would help resolve where the DNAJB6b-mRFP cells are located in both embryonic and adult hearts (i.e. only myocardium?).</p><p>3. Electrical data from ECGs should be reported. This would support characterization of the specific conduction phenotypes (e.g. PR, QT, QRS, RR intervals). This is relevant as DNAJB6 appears quite broadly expressed in both zebrafish and mouse hearts, and so it would be interesting to see if there is only an atrial conduction issue, or if ventricular conduction parameters are also affected.</p><p>4. The presence of ectopic atrial pacemakers and the early expression of DNAJB6b could suggest that SAN patterning is affected in GBT411 mutants. Does the sqET33 line expression pattern look different between GBT411-/- and WT embryos? Markers of SAN (isl1, HCN4) could also be used to address this question during developmental stages. Along these lines, is arrhythmia detected at larval stages in GBT411 mutants?</p><p>5. Transcriptomics data seems to be centred on the ion channels and WNT pathways genes. Are these Wnt factors transcriptional regulators of the ca<sup>2+</sup> channels? How is dnajb6 hypothesized to lead to transcriptional changes? Are these direct changes or a consequence of sustained SA and AVBs?</p><p>6. Have DNAJB6 variants been identified in SSS patients? Other arrhythmias?</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>1. The authors stated that DNAJB6b mutants were selected for in-depth characterization because they were most arrhythmogenic (lines 155-156). This is inconsistent with the data shown in Table 2.</p><p>2. The authors stated that DNAJB6b mutants' &quot;response to isoproterenol remained unchanged&quot; (lines 164-165). Based on what is presented in Supplemental Figure 1, DNAJB6b mutants responded to isoproterenol treatment in a manner like what was observed in wild type animals.</p><p>3. The cardiac expression of DNAJB6 needs further clarification.</p><p>a. The authors stated that DNAJB6 is enriched in SAN tissues (page 8). However, DNAJB6 appears to be expressed ubiquitously in the myocardium without obvious enrichment in SAN cells in fish (Figure 2).</p><p>b. Figure 2D, DNAJB6 is expressed in a broad range of cells which includes HCN4 positive cells. This is contradictory to what is stated in the abstract (lines 44-49) and discussion (lines 334-336).</p><p>c. The authors highlighted cells with high TBX3/low DNAJB6 and low TBX3/high DNAJB6 expression (Figure 2E). Could the authors explain how high/low expression is defined, how many cells have been examined and what percentage of cells showing high TBX3/low DNAJB6 and low TBX3/high DNAJB6 expression?</p><p>d. Figure 2F. islet1 staining shows high background.</p><p>4. The impacts of Dnajb6 loss on heart rhythm in mice was examined in heterozygotes because Dnajb6-/- died embryonically. There are some issues regarding these mutants that need to be clarified:</p><p>a. Could the authors clarify what stage do the homozygotes die and what stage are the hearts taken from mutants for Western blot? (Lines 213-216, Figure 3C).</p><p>b. In mice, sinus arrest and AV block were noted in Dnajb6 +/-. Could the authors provide quantification? How many animals were examined? What percentage of animals develop sinus arrest and what percentage with AV block?</p><p>c. Optical mapping revealed ectopic pacemaker activity in Dnajb6 +/- hearts. Could authors provide quantitative data?</p><p>5. What is the cellular basis of ectopic pacemaker activity in dnajb6 mutants? Are pacemaker cells damaged in Dnajb6 mutants?</p><p>6. Transcriptomic profiling.</p><p>a. Figure 6A. Missing log2FC value and p value for Gjb5.</p><p>b. Heatmap shown in sup. Figure 3B is quite unusual. Is it scaled?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.77327.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>(1) The manuscript needs to include new experiments that address the mechanism by which loss or reduction of DNAJB6 causes SSS.</p></disp-quote><p>We carried out the following experiments to address the cellular and molecular mechanisms underlying the observed SSS phenotypes. Based on these data, we added a new section to the Discussion section (Lines 425-466).</p><p>(1) In mice, we did more antibody immunostaining and confirmed a negative correlation in terms of expression intensity between the DNAJB6 and TBX3 proteins. We further detected a significantly increased TBX3 immunostaining signal in the SAN tissues of <italic>DNAJB6</italic> heterozygous mice compared to WT controls (new Figure 3D-F).</p><p>(2) In zebrafish, we compared expression patterns of the sqET33-mi59B conduction system reporter line between the <italic>GBT411/dnajb6b</italic> heterozygous and homozygous mutants. We found the atrio-ventricular canal (AVC) signal became diffused in <italic>GBT411/dnajb6b</italic> homozygous adult hearts. In addition, the ring-like structure usually seen in the SAN region of WT controls and in the <italic>GBT411/dnajb6</italic> heterozygous was largely lost in 3 out of 9 <italic>GBT411/dnajb6b</italic> homozygous adult hearts examined (new Figure 2).</p><p>Together with the ectopic pacemaker activity detected in the <italic>Dnajb6</italic> heterozygous mice (new Figure 5A and 5B), we speculate that DNAJB6 might act as a suppressor of TBX3 transcription factor in defining cell fate specification into SAN pacemaker myocytes. Since TBX3 was reported to suppress chamber myocardial differentiation (<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/?size=100&amp;term=Mommersteeg+MT&amp;cauthor_id=17234970">Mommersteeg</ext-link> et al., Circ Res. 2007;100(3):354-62), upregulation of TBX3 may thus contribute to enhanced atrial ectopic activity in <italic>Dnajb6</italic> heterozygous mice.</p><p>Furthermore, TBX3 has been recently identified as a component of the Wnt/β-catenin-dependent transcriptional complex (Zimmerli et al., <italic>eLife</italic>. 2020;9:e58123), which is significantly affected in Dnajb6 heterozygous mice (see new Figure 7B-C). This further supports a possible role of TBX3 in both SAN and atrial remodeling.</p><p>(3) Finally, in collaboration with Drs. Grandi, Morotti, and Ni from University of California Davis, we utilized a population-based computational modeling approach to determine the cellular/ionic mechanisms that could underlie the ex vivo observed SSS phenotype in the <italic>Dnajb6</italic> heterozygous mice (new Figure 6). We used our previously published model of the mouse SAN myocyte (Morotti et al. Int J Mol Sci. 2021; 22(11):5645) and enhanced it with addition of both sympathetic and parasympathetic stimulations to model the effects of isoproterenol- and carbachol-induced changes in pacemaker activity (i.e., firing rate), respectively. We generated a population of 10,000 mouse SAN myocyte models by random modification of selected model parameters describing maximum ion channel conductances and ion transport rates from the baseline model and assessed isoproterenol- and carbachol-induced effects on each model variant. We then separated this population of models in two subpopulations representing the WT and <italic>Dnajb6<sup>+/-</sup></italic> mice phenotypes: namely, we extracted the model variants that recapitulate changes observed in <italic>Dnajb6<sup>+/-</sup></italic> vs. WT mice, including a reduced firing rate at baseline, an increased response to isoproterenol, and a decreased response to carbachol administration (new Figure 6). This filtering process resulted in n=438 models that correspond to the <italic>Dnajb6<sup>+/-</sup></italic> mice phenotype and n=6,995 models that correspond to the WT phenotype. We analyzed the parameter value differences in these two subgroups to revealed several crucial parameters that are significantly correlated with the observed electrophysiological changes. The analysis revealed a significant decrease in the maximal conductances of the fast (Na<sub>v</sub>1.5) sodium current, the L-type ca<sup>2+</sup> current (<italic>I</italic><sub>Ca,L</sub>), the transient outward, sustained, and acetylcholine-activated K<sup>+</sup> currents, the background Na<sup>+</sup> and ca<sup>2+</sup> currents, as well as the ryanodine receptor maximal release flux of the <italic>Dnajb6<sup>+/-</sup></italic> vs. WT model variants. We also found a significant increase in the Na<sup>+</sup>/ca<sup>2+</sup> exchanger (NCX) maximal transport rate, and conductances of the T-type ca<sup>2+</sup> current and the slowly-activating delayed rectifier K<sup>+</sup> current. These new studies provide some novel mechanistic insights into the observed SSS phenotype in <italic>Dnajb6<sup>+/-</sup></italic> mice. Importantly, these new <italic>in silico</italic> experiments add another conceptual level to the phenotype-based screening approach introduced in the current study to identify new genetic factors associated with SAN dysfunction. Direct testing of these mechanisms would require a substantial amount of single SAN cell patch clamp and confocal microscopy experiments which are out of scope of the current manuscript and will be pursued in a follow-up study.</p><disp-quote content-type="editor-comment"><p>(2) The manuscript needs to have a better characterization of Dnaj6b expression in the heart and to strengthen the claim that the arrhythmia is not due to cardiomyopathy/structural remodeling in both zebrafish and mice.</p></disp-quote><p>(1) In zebrafish, we obtained higher quality images of <italic>GBT411/sqET33-mi59B</italic>, demonstrating partially overlapping expression of the EGFP reporter in the sqET33-mi59B line with the dnajb6b-mRFP fusion protein in the <italic>GBT411</italic> mutants during both embryonic and adult stages (new Figure 2).</p><p>(2) In mice, we obtained higher resolution images of antibody immunofluorescence staining in the <italic>Dnajb6<sup>+/-</sup></italic> mice and demonstrated that DNAJB6 is partially co-localized with the HCN4 protein and showed a complementary expression with TBX3 in the SAN (new Figure 3).</p><p>(3) In mice, we also carried out more histology analysis experiments to examine left ventricular (LV) structure in <italic>Dnajb6<sup>+/-</sup></italic> mice at 1 year of age, using H&amp;E staining, Masson’s Trichrome staining, and transmission electron microscopy (TEM) analysis. We now show clearly that there are no significant myocardium structural changes in the LV tissues of <italic>Dnajb6<sup>+/-</sup></italic> mice, when the SSS phenotype was already noticeable (new Figure 4—figure supplement 1). In addition, we did more detailed fibrotic contents analysis in the atrial and SAN tissues of <italic>Dnajb6<sup>+/-</sup></italic> mice at 1 year of age and detected no significant changes as well (new Figure 5—figure supplement 2). Together, these new data further confirm the absence of structural remodeling in <italic>Dnajb6<sup>+/-</sup></italic> mice and highlight a direct effect of <italic>Dnajb6</italic> on SAN dysfunction.</p><p>(4) Finally, in zebrafish, we examined myocardium ultrastructure in the <italic>GBT411/dnajb6b</italic> heterozygous fish at ~2 years of age by using TEM analysis. We detected severe sarcomere structural changes in 1 out of 3 fish hearts examined (see <xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>). Because both arrhythmia and myocardium structural abnormality were detected in fish at this age, this experiment cannot be used to support the statement that arrhythmia is not due to structural remodeling. An earlier time point will be needed in the future.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Myocardium structural defects were detected in the <italic>GBT411</italic> heterozygous mutant at 2 years of age.</title><p>Shown are transmission electron microscopy micros (TEM) images of WT and <italic>GBT411</italic> heterozygous mutant heart ventricles at 2 years of age. Arrows point to round-shape and swollen mitochondrial. Stars indicate degenerated sarcomeric Z-discs. Scale bars, 5µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77327-sa2-fig1-v2.tif"/></fig><p>Together, we have obtained more experimental evidence to strengthen the claim that arrhythmia is not due to cardiomyopathy/structural remodeling in the <italic>Dnajb6<sup>+/-</sup></italic> mice. However, the evidence from fish remains weak. Therefore, we removed the claim that “when structural remodeling/cardiac dysfunction have not yet occurred” in fish and modified our statement in mice accordingly (Lines 375-378, 386-389).</p><disp-quote content-type="editor-comment"><p>(3) The manuscript needs to address evidence or lack of evidence for a role of DNAJ6B in SSS in humans.</p></disp-quote><p>(1) From a recent GWAS study based on 6,469 SSS cases and 1,000,187 controls, a dataset for genetic variants for SSS have been reported (Thorolfsdotir et al., Eur Heart J, 2021;42(20):1959-1971). We searched DNAJB6 variants from this database and identified four variants with P&lt;0.05, among which two are located in untranslated regions. One variant, rs754941044 (P=0.0193), is predicted as a splice acceptor variant by the Ensembl variant effect predictor, which is likely to have a significant impact on DNAJB6 gene function (new Supplementary File 4). We added this data to the main text (Lines 320-328).</p><p>(2) We performed targeted genetic screening of the translated sequence of DNAJB6 in DNA of 162 human SSS patients enrolled in Xinhua hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China, for possible disease association. We identified one variant from one patient, as shown in the <xref ref-type="table" rid="sa2table1">Author response table 1</xref>.</p><table-wrap id="sa2table1" position="float"><label>Author response table 1.</label><caption><title>Identification of the <italic>DNAJB6</italic> variant from patients with sick sinus syndrome (n=162).</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Nucleotide change (protein change)</th><th>Genotyoe frequency</th><th>ExAC MAF frequency (%)</th><th>Clinical phenotype</th><th>SIFT prediction (score)</th><th>PolyPhen Prediction (score)</th></tr></thead><tbody><tr><td align="left" valign="top">c.145G&gt;T (p.V49L)</td><td align="left" valign="top">0/8600 (EVS)<break/>1/95768 (ExAC)<break/>1/140242 (GnomAD)<break/>1/162 (SSS)</td><td align="left" valign="top">0</td><td align="left" valign="top">Sick Sinus syndrome</td><td align="left" valign="top">Tolerate (o.142)</td><td align="left" valign="top">Damaging (0.972)</td></tr></tbody></table></table-wrap><p>EVS, exome variant server; ExAC, exome aggregationconsortiu; GnomAD, gemone aggregation database; MAF, minor allele frequency; SIFT, sorting intolerant; SSS, sick sinus syndrome</p><p>Because our current evidence is still relatively weak – more pathogenic variants would need to be identified and functional validation of their pathogenicity need to be performed, we decided to not include these data in the present manuscript.</p><p>Taken together, in the Discussion section, we state that “Prompted by our preliminary success in identifying potentially significant sequence variances for DNAJB6 from human SSS patients, future human genetic studies are warranted to search more sequence variants and to confirm their pathogenicity, which are required to firmly establish DNAJB6 as a SSS causative gene in human.” (Lines 391-395)</p><disp-quote content-type="editor-comment"><p>(4) The revision should include the suggested recommendations on data presentation and analysis.</p></disp-quote><p>Thanks to reviewer’s suggestions on our data presentation. We carefully revised the manuscript accordingly. Below please see our point-to-point response to reviewers’ comments, and suggested recommendations on data presentation and analysis as well.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>The first screen is not clearly described. While it is indicated that both heterozygous and homozygous carriers were screened, it appears that all phenotypic individuals were heterozygotes according to legend of Figure 1. Why no homozygotes were identified in the screen is not discussed. In the pilot screen, both SA and AVB were observed in the initial screen for GBT103. It is not made clear if they occur in the same individuals. In the homozygote screen, only SA incidence was assessed. It is unknown if there was no AVB or it was not assessed.</p></disp-quote><p>(1) We initially performed the pilot screen in aged, mRFP positive GBT mutant fish generated from incrosses, thus containing both heterozygous and homozygous carriers. For our initial screen, we did not breed all GBT lines to homozygosity purposely because of the significantly increased colony management efforts. After candidate GBT lines with SSS phenotypes have been identified, we then selectively bred these GBT lines to homozygous animals. We now clarified this point in the text (Lines 133-134, 138-142).</p><p>(2) We now confirm that SA and AVB were detected in different animals of the <italic>GBT103</italic> mutants mixed with heterozygous and homozygous in the initial pilot screen. In the homozygote confirmation experiments, there was only 1 out of 7 <italic>GBT103</italic> homozygous fish (15%), and 1 out of 10 <italic>GBT411</italic> homozygous fish (10%) manifesting AVB. We added these AVB data and revised the Table 2 accordingly and clarified these details in the main text (Lines 142-143, 153-154).</p><disp-quote content-type="editor-comment"><p>The RNAseq analysis was done in 1 year old mice. It is a stretch to link the observed changes in Wnt signaling pathway to developmental defects, which is also not supported by the histological data provided.</p></disp-quote><p>We agree that it might be a stretch to conclusively link Wnt signaling pathway with <italic>Danjb6</italic> mutant phenotypes. However, it is a very intriguing data that RNAseq data uncovered a change in Wnt signaling that have been linked to SAN development. We toned down our conclusions and pointed out this stretch, so that readers can properly interpret these data (Lines 315-319).</p><p>Nevertheless, we detected a negative correlation in terms of expression intensity between the DNAJB6 and TBX3 proteins and further found a significantly increased TBX3 signal in the SAN tissues of <italic>Dnajb6</italic> heterozygous mice compared to WT controls (new Figure 3). Since TBX3 suppresses chamber myocardial differentiation (Circ Res. 2007;100(3):354-62), upregulation of TBX3 may thus contribute to enhanced atrial ectopic activity observed in <italic>Dnajb6</italic> heterozygous mice. These findings provide some mechanistic insights into the observed arrhythmic phenotype and highlight specific signaling pathways that need to be further addressed in future studies.</p><disp-quote content-type="editor-comment"><p>Since GWAS studies have been reported, can the authors find any evidence from these studies for a role of DNAJB6 in SSS?</p></disp-quote><p>(1) From a recent GWAS study based on 6,469 SSS cases and 1,000,187 controls, a dataset for genetic variants for SSS have been reported (Thorolfsdotir et al., Eur Heart J, 2021;42(20):1959-1971). We searched <italic>Dnajb6</italic> variants from this database and identified four variants with <italic>P</italic>&lt;0.05, among which two are located in untranslated regions. One variant, <italic>rs754941044</italic> (<italic>P</italic>=0.0193), is predicted as a splice acceptor variant by the Ensembl variant effect predictor, which is likely to have a significant impact on <italic>Dnajb6</italic> gene function (new Supplementary File 4). We added this data to the main text (Lines 320-328).</p><p>(2) We performed targeted genetic screening of the translated sequence of <italic>Dnajb6</italic> in DNA of 162 human SSS patients enrolled in Xinhua hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China, for possible disease association. We identified one variant from one patient, as shown in the Response-only Table 1. Because our current evidence is still relatively weak – more pathogenic variants would need to be identified and functional validation of their pathogenicity need to be performed, we decided to not include these data in the present manuscript.</p><p>Taken together, in the Discussion section, we stated that “Prompted by our preliminary success in identifying potentially significant sequence variances for <italic>Dnajb6</italic> from human SSS patients, future human genetic studies are warranted to search more sequence variants and to confirm their pathogenicity, which are required to firmly establish <italic>Dnajb6</italic> as a new human <italic>SSS</italic> causative gene.” (Lines 391-395)</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Overall, this manuscript presents some exciting findings that nicely illustrate the strength of the using adult ZIC lines in a phenotypic screen for a difficult disease to model in vivo. The following recommendations are suggested to strengthen the functional studies, as some of the conclusions in the manuscript are poorly supported.</p><p>1. The claim that the zebrafish and mouse models do not have cardiomyopathy/structural remodelling is not supported by the current data. At a minimum, histology and fibrotic markers should be included. This is also important given a previous report (Ding, JCI 2016) indicated cardiomegaly in the GBT411 line. As the <italic>Dnajb6</italic>-short isoform colocalizes to the sarcomere, it would be important to show how cardiac muscle appears in GBT411/dnajb6b hets and mutants, as well as in the Dnajb6 het mouse heart.</p></disp-quote><p>We carried out more experiments to examine left ventricular (LV) structure in <italic>Dnajb6</italic> heterozygous mice at 1 year of age, using H&amp;E staining, Masson’s Trichrome staining, and transmission electron microscopy (TEM) analysis. We now show clearly that there are no significant myocardium structural changes in the LV as well as atrial and SAN tissues of <italic>Dnajb6</italic> heterozygous mice (new new Figure 4—figure supplement 1, Figure 5—figure supplement 2), when the SSS phenotype was already noticeable. However, in the <italic>GBT411/dnajb6b</italic> heterozygous mutant at ~2 years of age, we detected severe sarcomere structural abnormality in 1 out of 3 fish hearts examined (see Response-only Figure 1). In addition, in a previous publication (Ding et al., Circ Res, 2013:112(40:606-17)), we reported evident cardiac remodeling phenotypes in the <italic>GBT411/dnajb6b</italic> homozygous fish at 12 months of age.</p><p>Together, we have obtained more experimental evidence to strengthen the claim that arrhythmia is not due to cardiomyopathy/structural remodeling in the <italic>Dnajb6<sup>+/-</sup></italic> mice. However, the evidence from fish remains weak. Therefore, we removed the claim that “when structural remodeling/cardiac dysfunction have not yet occurred” in fish and modified our statement in mice accordingly (Lines 375-378, 386-389).</p><disp-quote content-type="editor-comment"><p>2. Expression patterns in zebrafish should be more clearly visualized and discussed. For example, does the mRFP from GBT411/dnajb6b colocalize with sqET33-mi59B expression in the atrioventricular canal cells at 3 dpf (only the SAN is shown), or in the adult SAN cells (only AVC is shown)? Other markers would help resolve where the Dnajb6b-mRFP cells are located in both embryonic and adult hearts (i.e. only myocardium?).</p></disp-quote><p>Thanks for these suggestions. We carried out more experiments to visualize and compare the mRFP patterns in the <italic>GBT411/Dnajb6b</italic> mutants to the EGFP expression in the conduction system reporter line of sqET33-mi59B. Our new data clearly showed that <italic>GBT411/mRFP</italic> colocalized with the sqET33-mi59B/EGFP in both atrioventricular canal (AVC) cells and SAN in the atrium, in both embryonic (3 dpf) and adult hearts (new Figure 2).</p><disp-quote content-type="editor-comment"><p>3. Electrical data from ECGs should be reported. This would support characterization of the specific conduction phenotypes (e.g. PR, QT, QRS, RR intervals). This is relevant as Dnajb6 appears quite broadly expressed in both zebrafish and mouse hearts, and so it would be interesting to see if there is only an atrial conduction issue, or if ventricular conduction parameters are also affected.</p></disp-quote><p>For both mice and fish, we added quantification data for other ECG parameters including PR interval, QT interval, QRS duration and RR interval as suggested (new Supplementary Files 2 and 3). Our quantification detected no statistically significant changes, except for increased RR intervals in mutants, which is consistent with the observed heart rate reduction.</p><disp-quote content-type="editor-comment"><p>4. The presence of ectopic atrial pacemakers and the early expression of Dnajb6b could suggest that SAN patterning is affected in GBT411 mutants. Does the sqET33 line expression pattern look different between GBT411-/- and WT embryos? Markers of SAN (isl1, HCN4) could also be used to address this question during developmental stages. Along these lines, is arrhythmia detected at larval stages in GBT411 mutants?</p></disp-quote><p>We didn’t detect arrhythmia phenotypes at larval stages in the <italic>GBT411</italic> mutants. The late-onset and milder phenotypes in zebrafish than mouse is probably owning to the existence of two <italic>Dnajb6</italic> homologues in zebrafish, but a single <italic>Dnajb6</italic> homologue in mouse.</p><p>Thanks to your question, we compared more carefully the expression patterns of sqET33 line expression patterns between <italic>GBT411/dnajb6b</italic> heterozygous and homozygous mutants and WT control in both embryonic and adult hearts. We didn’t see obvious differences in embryonic hearts. However, in adult hearts, we found that the AVC signal became diffused and SAN signal was largely lost in 3 out of 9 <italic>GBT411/dnajb6b</italic> homozygous mutant hearts examined comparing to <italic>GBT411/dnajb6b</italic> heterozygous mutant (new Figure 2).</p><disp-quote content-type="editor-comment"><p>5. Transcriptomics data seems to be centred on the ion channels and WNT pathways genes. Are these Wnt factors transcriptional regulators of the ca<sup>2+</sup> channels? How is DNAJB6 hypothesized to lead to transcriptional changes? Are these direct changes or a consequence of sustained SA and AVBs?</p></disp-quote><p>Our RNAseq data suggested that <italic>Dnajb6</italic> might transcriptionally regulate expression of genes in Wnt pathway and ca<sup>2+</sup> channel, providing clues for future mechanistic studies. At this stage, we do not have evidence supporting that Wnt factors are transcriptional regulators of the ca<sup>2+</sup> channels. Because the RNAseq was done using 1 year mice when SSS is obvious, it is less likely that these transcriptional changes are direct consequences of <italic>Dnajb6</italic> gene knockout. Longitudinal studies are needed in the future to answer these mechanistic questions.</p><disp-quote content-type="editor-comment"><p>6. Have DNAJB6 variants been identified in SSS patients? Other arrhythmias?</p></disp-quote><p>(1) From a recent GWAS study based on 6,469 SSS cases and 1,000,187 controls, a dataset for genetic variants for SSS have been reported (Thorolfsdotir et al., Eur Heart J, 2021;42(20):1959-1971). We searched <italic>DNAJB6</italic> variants from this database and identified four variants with <italic>P</italic>&lt;0.05, among which two are located in untranslated regions. One variant, <italic>rs754941044</italic> (<italic>P</italic>=0.0193), is predicted as a splice acceptor variant by the Ensembl variant effect predictor, which is likely to have a significant impact on <italic>DNAJB6</italic> gene function (new Supplementary File 4). We added this data to the main text (Lines 320-328).</p><p>(2) We performed targeted genetic screening of the translated sequence of <italic>DNAJB6</italic> in DNA of 162 human SSS patients enrolled in Xinhua hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China, for possible disease association. We identified one variant from one patient, as shown in the Response-only Table 1. Because our current evidence is still relatively weak – more pathogenic variants would need to be identified and functional validation of their pathogenicity need to be performed, we decided to not include these data in the present manuscript.</p><p>Taken together, in the Discussion section, we stated that “Prompted by our preliminary success in identifying potentially significant sequence variances for <italic>DNAJB6</italic> from human SSS patients, future human genetic studies are warranted to search more sequence variants and to confirm their pathogenicity, which are required to firmly establish <italic>DNAJB6</italic> as a new human <italic>SSS</italic> causative gene.” (Lines 391-395)</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>1. The authors stated that Dnajb6b mutants were selected for in-depth characterization because they were most arrhythmogenic (lines 155-156). This is inconsistent with the data shown in Table 2.</p></disp-quote><p>In addition to increased incidence of SA, the <italic>GBT411/GBT411</italic> homozygous mutant also showed a significantly reduced heart rate, which does not occur in the other 2 candidate SSS mutants. Since the <italic>GBT103</italic> and <italic>GBT411</italic> mutants manifested similar tendency in terms of heart rate reduction, we removed the previous claim of <italic>GBT411</italic> as the most arrhythmogenic line and edited the abstract accordingly (Lines 45-46, 157-159).</p><disp-quote content-type="editor-comment"><p>2. The authors stated that Dnajb6b mutants' &quot;response to isoproterenol remained unchanged&quot; (lines 164-165). Based on what is presented in Supplemental Figure 1, Dnajb6b mutants responded to isoproterenol treatment in a manner like what was observed in wild type animals.</p></disp-quote><p>Thank you for pointing out this. We modified our statements by stating that “while its response to isoproterenol treatment appeared to be similar to that in WT control animals” (Lines 168-169).</p><disp-quote content-type="editor-comment"><p>3. The cardiac expression of Dnajb6 needs further clarification.</p><p>a. The authors stated that Dnajb6 is enriched in SAN tissues (page 8). However, Dnajb6 appears to be expressed ubiquitously in the myocardium without obvious enrichment in SAN cells in fish (Figure 2).</p></disp-quote><p>In zebrafish myocardium, the expression of DNAJB6b indeed appears to be ubiquitous, unlike its more specific expression pattern in mouse SAN. Nevertheless, when we tried to define its expression in the conduction system through crossing into the sqET33-mi59B transgenic line in which EGFP labels the zebrafish SAN and atrio-ventricular canal (AVC) cells, we found the EGFP reporter partially overlapped with the Dnajb6b-mRFP fusion protein in the <italic>GBT411</italic> mutant during both embryonic and adult stages (new Figure 2)</p><disp-quote content-type="editor-comment"><p>b. Figure 2D, DNAJB6 is expressed in a broad range of cells which includes HCN4 positive cells. This is contradictory to what is stated in the abstract (lines 44-49) and discussion (lines 334-336).</p></disp-quote><p>Thank you for pointing out this error. Indeed, DNAJB6 antibody staining positive cells do partially, despite not completely, overlap with HCN4 positive Cells. We edited the abstract (Lines 48-49) and discussion (Lines 396-399) accordingly.</p><disp-quote content-type="editor-comment"><p>c. The authors highlighted cells with high TBX3/low DNAJB6 and low TBX3/high DNAJB6 expression (Figure 2E). Could the authors explain how high/low expression is defined, how many cells have been examined and what percentage of cells showing high TBX3/low DNAJB6 and low TBX3/high DNAJB6 expression?</p></disp-quote><p>We used the Zeiss Zen software equipped with the Zen2 microscope system to quantify the DNAJB6 and TBX3 signal intensity after antibody co-immunostaining. Our results (n=20 cells) showed a negative correlation between the DNAJB6 and TBX3 signal with an R<sup>2</sup> of 0.8145 (new Figure 3E).</p><disp-quote content-type="editor-comment"><p>d. Figure 2F. islet1 staining shows high background.</p></disp-quote><p>Indeed, the Islet1 antibody immunostaining staining signal showed high background in our hands. We have tried 3 more commercially available antibodies (from abcam, catalog#: ab109517; from Developmental Studies hybridoma Bank (DSHB), catalog# 39.3F7 and 40.3A4) using SAN tissues dissected from adult mice hearts, but failed to obtain better images. To improve stringency of this manuscript, we took out of those Islet1 staining results and modified the text accordingly.</p><disp-quote content-type="editor-comment"><p>4. The impacts of DNAJB6 loss on heart rhythm in mice was examined in heterozygotes because Dnajb6-/- died embryonically. There are some issues regarding these mutants that need to be clarified:</p><p>a. Could the authors clarify what stage do the homozygotes die and what stage are the hearts taken from mutants for Western blot? (Lines 213-216, Figure 3C).</p></disp-quote><p>The <italic>Dnajb6</italic> homozygous mice died in uterus at about E13.5 stage. We did Western blot using protein lysates extracted from the E12.5 stage embryonic hearts after PCR genotyping analysis. We clarified these details in the main text according (Lines 229-233, 563-569).</p><disp-quote content-type="editor-comment"><p>b. In mice, sinus arrest and AV block were noted in Dnajb6 +/-. Could the authors provide quantification? How many animals were examined? What percentage of animals develop sinus arrest and what percentage with AV block?</p></disp-quote><p>15 out of 44 the <italic>Dnajb6+/-</italic> mice examined manifested sinus arrest phenotype and 3 out of 44 exhibited av block, accounting for 33.4% and 6.8%, respectively. we now provide animal numbers and percentages of animals exhibiting sa or avb phenotypes in the <italic>Dnajb6+/-</italic> mutants in table 4.</p><disp-quote content-type="editor-comment"><p>c. Optical mapping revealed ectopic pacemaker activity in Dnajb6 +/- hearts. Could authors provide quantitative data?</p></disp-quote><p>We quantified the results shown in Figure 5B and added the <italic>p</italic> value. We used Fisher's exact test for statistical analysis of pacemaker redistribution in <italic>Dnajb6</italic> heterozygous mice and found <italic>p</italic>=0.0395 for the observed pattern of pacemaker distribution between WT and Dnajb6 mice. The Figure and corresponding Figure legend have been modified accordingly.</p><disp-quote content-type="editor-comment"><p>5. What is the cellular basis of ectopic pacemaker activity in Dnajb6 mutants? Are pacemaker cells damaged in Dnajb6 mutants?</p></disp-quote><p>Based on the diffused AV canal signal and SAN signal loss in the <italic>GBT411/dnajb6</italic> homozygous mutant, and a negatively correlated expression of DNAJB6 with TBX3 in the mouse SAN tissues, we speculate that DNAJB6 might acts as a suppressor of TBX3 transcription factor to define SAN cell specification. This potential mechanism is also supported by the observation in mice that loss-of-function of Dnaj6b results in conduction system defects and ectopic pacemaker activity. Since TBX3 suppresses chamber myocardial differentiation (<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/?size=100&amp;term=Mommersteeg+MT&amp;cauthor_id=17234970">Mommersteeg</ext-link> et al., Circ Res. 2007;100(3):354-62), upregulation of TBX3 may thus contribute to enhanced atrial ectopic activity in DNAJB6 heterozygous mice.</p><p>Furthermore, TBX3 has been recently identified as a component of the Wnt/β-catenin-dependent transcriptional complex (Zimmerli et al., <italic>eLife</italic>. 2020;9:e58123), which is significantly affected in Dnajb6 heterozygous mice (see new Figure 7B-C). This further supports a possible role of TBX3 in both SAN and atrial remodeling.</p><p>We did Trichrome Masson’s staining using SAN tissues from the Dnajb6 heterozygous mice and WT controls but didn’t detect any significant fibrosis changes (new Figure 5—figure supplement 2). Therefore, it is likely pacemakers are not damaged but their expression patterns altered in the Dnajb6 mutants.</p><p>All the observed ectopic pacemakers were located within the region of extensive distributed system of atrial pacemakers (the atrial pacemaker complex), which includes but extends well beyond an anatomically defined SAN (Boineau et al., Circulation 58: 1036–1048, 1978; Boineau et al., Circulation 77: 1221–1237, 1988; Glukhov et al., Am J Physiol Heart Circ Physiol 299:H482-H491, 2010). Cells located in the region between the superior vena cava and atrio-ventricular node and between the crista terminalis and inter-atrial septum, show a positive expression of pacemaker cell marker HCN4 (see <xref ref-type="fig" rid="sa2fig2">Author response image 2</xref>). While the SAN cells are characterized by HCN4-negative and Connexin43 (Cx43, working myocardium-specific gap junction protein)-negative expression pattern, subsidiary atrial pacemakers have both HCN4- and Cx43-positive expression. In normal physiological conditions, spontaneous activity of subsidiary pacemakers is overdrive suppressed by the SAN. However, when SAN function is diminished (i.e., during SSS, as observed in Dnajb6 heterozygous mice), subsidiary pacemakers can produce escape beats leading to pacemaker irregularities and significant heart rate lability.</p><p>Though these subsidiary pacemaker clusters can provide a relatively regular rhythm, they are characterized by a slower resting heart, slower exertional heart rates, a prolonged post-pacing recovery time (a parameter similar to SAN recovery time but for non-SAN pacemakers), and an increased beat-to-beat heart rate variability (Morris et al., Cardiovasc Res 2013, 100, 160–169; Choudhury et al., J Physiol 2018, 596, 6141–6155). Furthermore, the electrical activity of this subsidiary pacemakers is more akin to that of the SAN than to the surrounding atrial muscle; the subsidiary pacemaker action potential exhibits prominent diastolic depolarization and a significantly lower maximum diastolic potential, take-off potential, overshoot, rate of rise, and amplitude than typical atrial muscle (Rozanski et al., JACC 1984, 4, 535–542). Finally, while being bradycardic in general, subsidiary atrial pacemakers can contribute to the development of atrial tachycardia (Kalman et al., JACC 1998, 31, 451–459; Marrouche et al., JACC 2002, 40, 1133–1139). Therefore, we could hypothesize that TBX3 overexpression observed in Dnajb6 heterozygous mice, could further facilitate pacemaker activity in cells within the extended atrial pacemaker complex and, maybe, promote atrial arrhythmogenesis in the setting of profound structural remodeling. These suggestions have been included in the revised Discussion section.</p><fig id="sa2fig2" position="float"><label>Author response image 2.</label><caption><title>3-D reconstruction of the entire mouse SAN preparations was used for immunofluorescent labeling of connexin 43 (Cx43, green) and HCN4 (red).</title><p>Mosaic images were created by superimposing of 3-D Z-stacks (averaged through 30-50 scanned layers; 50-200 μm thickness) of different regions throughout the SAN pacemaker complex. Pacemaker regions are shown to be characterized by HCN4-positive staining. From Glukhov et al. Eur Heart J. 2015 Mar 14;36(11):686-97.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77327-sa2-fig2-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>6. Transcriptomic profiling.</p><p>a. Figure 6A. Missing log2FC value and p value for Gjb5.</p></disp-quote><p>We add log2FC value and <italic>p</italic> value data back for the <italic>Gjb5</italic> gene.</p><disp-quote content-type="editor-comment"><p>b. Heatmap shown in sup. Figure 3B is quite unusual. Is it scaled?</p></disp-quote><p>We double checked the heatmap and confirm the scale is correct. We used the function “Pheatmap” in Deseq package with default parameter settings, i.e., the values was centered and scaled within each sample. We do share the same concern that the order to show DE gene in “<italic>Dnajb6<sup>+/-</sup></italic>” and “WT” is somewhat unusual. We tried to switch it but couldn’t, because the program automatically did it during the clustering process.</p></body></sub-article></article>